Back

Logo Reference Ranges Report
Sorted by longname,ordercode    {click on appropriate heading to sort}
Test NameOrder CodeTest CodeMethodReference Ranges
VANILLYLMANDELIC ACID & HOMOVANILLIC ACID URINE (QUANTITATIVE)HVVMUQHVVMUQHPLC
Volume                          mL
Collection Period               hr
VMA               0.0-7.0       mg/d
HVA               0.0-15.0      mg/d
Creatinine, Ur                  mg/d
Creatinine, Ur                  mg/dL
 M 0-2 yrs     Not established
   3-8 yrs     140-700
   9-12 yrs    300-1300
   13-17 yrs   500-2300
   18-50 yrs   1000-2500       
   51-80 yrs   800-2100
   81+ yrs     600-2000
 F 0-2 yrs     Not established
   3-8 yrs     140-700
   9-12 yrs    300-1300
   13-17 yrs   400-1600
   18-50 yrs   700-1600
   51-80 yrs   500-1400
   81+ yrs     400-1300
Interpretation   Normal
VMA, Urine                      mg/gCr
   0-2 yrs     0-27
   3-5 yrs     0-13
   6-17 yrs    0-9
   18 yrs +    0-6
HVA, Urine                      mg/gCr
   0-2 yrs     0-42
   3-5 yrs     0-22
   6-17 yrs    0-15
   18 yrs +    0-8
11-DEOXYCORTISOL, SERUM (QUANTITATIVE)11DQS11DQSTandem Mass Spectrometry
11-Deoxycortisol, Serum         ng/dL
  Premature 26-28 wks     110-1376
  Premature 29-36 wks     70-455
  Term 1-5 mo             10-200
  Term 6-11 mo            10-156
  1-6 yrs                 7-210
 F 7-9 years              94 or less
   10-12 years            123 or less
   13-15 years            107 or less
   16-17 years            47 or less
   18 yrs & more          LT 33
 M 7-9 years              120 or less
   10-12 years            92 or less
   13-15 years            95 or less
   16-17 years            106 or less
   18 years & moe         LT 50
 By Tanner Stage
 F Tanner 1               94 or less
   Tanner 2               136 or less
   Tanner 3               99 or less
   Tanner 4-5             50 or less
 M Tanner 1               105 or less
   Tanner 2               108 or less
   Tanner 3               111 or less
   Tanner 4-5             83 or less
 After metyrapone stimulation GT 8000
14-3-3 PROTEIN, CSF (PRION DISEASE)PRIONPRIONImmunoassay
14-3-3 Protein, CSF   See separate report
17-ALPHA-HYDROXYPROGESTERONE17AHYD17AHYDRIA/Column
17-Alpha-hydroxyprogesterone     ng/dL
 M            27-199  
 F 
  Follicular  15-70
  Luteal      35-290
17-HYDROXYCORTICOSTEROIDS17OHQ17OHQPorter-Silber Reaction
Collection Period          h
Volume                     mL
17-Hydroxycorticosteroids  mg/d
 Urine
 4.0-14.0
17-Hydroxycoricosteroids   mg/gCr
 2.0-6.5
Creatinine, Urine          mg/dL
Creatinine, Urine          mg/d
 M 3-8 yrs     140-700
   9-12 yrs    300-1300
   13-17 yrs   500-2300
   18-50 yrs   1000-2500
   51-80 yrs   800-2100
   81 yrs +    600-2000
 F 3-8 yrs     140-170
   9-12 ys     300-1300
   13-17 yrs   400-1600
   18-50 yrs   700-1600
   52-80 yrs   500-1400
   81 yrs +    400-1300
17-HYDROXYPROGESTERONEOH-PROGEST17HYDRIA
17-Hydroxyprogesterone          ng/dL
 F Premature 26-28 weeks   124-841
   Premature 29-35 weeks   26-568
   Full term day 3         7-77
   4 days-1 month          7-106
   1-11 mons               13-106
   1-6 yrs                 4-115
   7-9 yrs                 71 or less
   10-12 yrs               129 or less
   13-15 yrs               9 to 208
   16-17 yrs               178 or less
   18 yrs +                LT 207
   Follicular              15-70
   Luteal                  35-290
   Tanner Stage I          74 or less
   Tanner Stage II         164 or less
   Tanner Stage III        13-209
   Tanner Stage IV-V       7-170
 M Premature 26-28 weeks   124-841
   Premature 29-35 weeks   26-568
   Full term day 3         7-77
    Levels increase after the first
    week to peak values ranging from
    40-200 ng/dL between 30-60 days.
    Values decrease to the range of
    3-90 ng/dL before year 1.
   1-6 yrs                 4-115
   7-9 yrs                 63 or less
   10-12 yrs               79 or less
   13-15 yrs               9 to 140
   16-17 yrs               24 to 192
   18 yrs +                LT 139
   Tanner Stage I          62 or less
   Tanner Stage II         104 or less
   Tanner Stage III        152 or less
   Tanner Stage IV-V       20-173
17-KETOSTEROIDS, URINEKETO17KSUQSpectrophotometric (Zimmerman Reaction)
Collection Period                   h
Volume                              mL
17 Keto Steroids                    mg/L
17 Keto Steroids                    mg/d
   Up to 1 yr    0.0-1.0 
   1-5 yrs       1.0-2.0
 M 6-10 yrs      1.0-4.4
   11-12 yrs     1.3-8.5
   13-16 yrs     3.4-9.8
   17-50 yrs     5.3-17.6
   50+ yrs       4.1-12.1
 F 6-10 yrs      1.4-3.9
   11-12 yrs     3.8-9.5
   13-16 yrs     4.5-17.1
   17-50 yrs     4.4-14.2
   50+ yrs       3.2-10.6
Creatinine, Urine                   mg/dL
Creatinine, Urine                   mg/d
 M 0-2 yrs     Not established
   3-8 yrs     140-700
   9-12 yrs    300-1300
   13-17 yrs   500-2300  
   18-50 yrs   1000-2500            
   51-80 yrs   800-2100
   81+ yrs     600-2000
 F 0-2 yrs     Not established
   3-8 yrs     140-700
   9-12 yrs    300-1300
   13-17 yrs   400-1600
   18-50 yrs   700-1600
   50-80 yrs   500-1400
   81+ yrs     400-1300
17-KETOSTEROIDS, URINE (FRACTIONATED)17-KETO FRAC17FRUQGC/MS
Collection Period  h
Volume             mL
17-Ketosteroids    See separate report to Follow
17-OH PREGNENOLONE17OHPG17OHPGRIA/ Column Chromatography
17-OH Pregnenolone     ng/dL
 0-15 yrs   44-235 
 16+ yrs    53-357
18-HYDROXYCORTICOSTERONE18OHCC18OHCCMS
18-Hydroxycorticosterone         ng/dL
 Premature infant           57-410
 Full-term infant
  3 days                    31-546
  1-12 months               5-220
 Children
  1-2 years                 18-155
  2-10 years                6-85
  10-15 years               10-72
 Adults                     9-58
  Normal Na intake
   8 am supine              4-21
   8 am upright             5-46
  Low Na intake
   8 am supine              11-75
   8 am upright             19-96
21-HYDROXYLASE ANTIBODIES21HYAB21HYABRIA
21-Hydroxylase Antibodies   0.0-1.0   U/mL
25 HYDROXYVITAMIN D2 & D325VD2325VD23LC-MS/MS
25-Hydroxyvitamin D2             ng/mL
25-Hydroxyvitamin D3             ng/mL
25-Hydroxyvitamin D Total        ng/mL
 Optimum levels in the normal
 population are 25-80.
3-ALPHA-ANDROSTANEDIOL GLUCURONIDE3-AAG3AAGEnzyme Digestion/Chrom/RIA
3-Alpha-Diol Glucuronide     ng/dL
 M Adult       260-1500   
 F Adult       60-300     
 Prepubertal   10-60      
  F  33-244 Tanner Stages II-III
  M  19-164 Tanner Stages II-III
3-METHOXY-4-HYDROXYPHENYLGLYCOL (MHPG), URINEMHPGUQMHPGUQHPLC
MHPG, Urine     0.9-3.5      mg/24h
 Therapeutic Indications
  Subclass I    LT 1.9
  Subclass II   GT 2.5
  Subclass III  1.9-2.5
 Additional Information is present in
 the Mayo Medical Lab Handbook.
 Note: Creatinine values between 16-25 
 mg/kg/day verifies 24-hour collection
 if renal function is within the
 reference range. 
Collection Period            h
Volume                       mL
5' NUCLEOTIDASE5NT5NTEnzymatic
5' Nucleotidase    0-15    U/L
5-FLUOROCYTOSINE, ANTIFUNGAL LEVELFUNABFUNABBA
5-Fluorocytosine Level      Peak serum         30.0-45.0        ug/mL
 Any undisclosed antibiotics might affect the results.
5-HIAA, URINE (QUANTITATIVE)5-HIAAHIAAUQHPLC/Electrochemical Detection
Collection Peiod       h
Volume                 mL
5-HIAA     0.0-10.0    mg/24h
5-HIAA, URINE (RANDOM)5HIAA.RHIAAURHPLC/Electrochemical Detection
5-HIAA, Urine Random    mg/L
  No normals established
ABO & RHABO/RHMABORHHemagglutination
ABO
RH
ABO GROUPABOM1ABOHemagglutination
ABO
ACETAMINOPHENTYLENTYLEnzymatic
Acetaminophen                          ug/mL
 Therapeutic  10-25
 Toxic        GT 150
ACETONEACETONEKETColorimetric
Acetone  Negative
ACETYLCHOLINE BINDING ANTIBODYAR-ABACETYLRIA
Acetylcholine Binding Ab      nmol/L 
 Negative  0.0-0.4         
 Positive  0.5 or greater
 Approximately 85-90% of patients with
 myasthenia gravis (MG) express anti-
 bodies to the acetylcholine receptor
 (AChR), which can be divided into
 binding, blocking, and modulating
 antibody. Binding antibody can activate
 complement and lead to loss of AChR.
 Blocking antibody may impair AChR
 binding to the receptor leading to
 poor muscle contraction. Modulating
 antibody causes receptor endocytosis
 resulting in loss of AChR expression,
 which correlates most closely with
 clinical severity of disease.
 Approximately 10-15% of individuals with 
 confirmed myasthenia gravis have no
 measurable binding, blocking or
 modulating antibody.
ACETYLCHOLINE RECEPTOR ANTIBODY PANELACHRPNACHRPNRIA & Radioreceptor Assay
ACHR Binding Antibody              nmol/L
 Negative              0.0-0.4
 Positive              0.5 or greater
ACHR Blocking Antibody             %
 Negative              0-15
 Indeterminate         16-24
 Positive              25 or greater
ACHR Modulating Antibody           %
 Negative              0-20
 Indeterminate         21-25
 Positive              26 or greater
 Approximately 85-90% of patients with
 myasthenia gravis (MG) express anti-
 bodies to the acetylcholine receptor
 (AChR), which can be divided into
 binding, blocking, and modulating
 antibody. Binding antibody can activate
 complement and lead to loss of AChR.
 Blocking antibody may impair AChR
 binding to the receptor leading to
 poor muscle contraction. Modulating
 antibody causes receptor endocytosis
 resulting in loss of AChR expression,
 which correlates most closely with
 clinical severity of disease.
 Approximately 10-15% of individuals with
 confirmed myasthenia gravis have no
 measurable binding, blocking or
 modulating antibody.
ACETYLCHOLINE RECEPTOR BLOCKING ANTIBODYAR.AB.BLOCKARABRIA
Acetylcholine Blocking Ab   0-15    %
 Interpretive Criteria
 Negative          0-15 % blocking
 Indeterminate     16-24 % blocking
 Positive          25 % blocking or more
 Approximately 85-90% of patients with
 myasthenia gravis (MG) express anti-
 bodies to the acetylcholine receptor
 (AChR), which can be divided into
 binding, blocking, and modulating
 antibody. Binding antibody can activate
 complement and lead to loss of AChR.
 Blocking antibody may impair AChR
 binding to the receptor leading to
 poor muscle contraction. Modulating
 antibody causes receptor endocytosis
 resulting in loss of AChR expression,
 which correlates most closely with
 clinical severity of disease.
 Approximately 10-15% of individuals
 confirmed myasthenia gravis have no
 measurable binding, blocking or
 modulating antibody.
ACETYLCHOLINE RECEPTOR MODULATING ANTIBODYACHRMOACHRMORadioreceptor Assay
ACHR Modulating Antibody           %
 Negative         0-20
 Indeterminate    21-25
 Positive         26 or greater
 Approximately 85-90% of patients with
 myasthenia gravis (MG) express anti-
 bodies to the acetylcholine receptor
 (AChR), which can be divided into
 binding, blocking, and modulating
 antibody. Binding antibody can activate
 complement and lead to loss of AChR.
 Blocking antibody may impair AChR
 binding to the receptor leading to
 poor muscle contraction. Modulating
 antibody causes receptor endocytosis
 resulting in loss of AChR expression,
 which correlates most closely with
 clinical severity of disease.
 Approximately 10-15% of individuals with 
 confirmed myasthenia gravis have no
 measurable binding, blocking or
 modulating antibody.
ACID FAST BACILLUS, MIC 12 DRUG PACKAGEshipping instruction codeM12NJM12NJBactec MIC
AFB MIC 12 Drug Package   
 See separate report
ACID FAST BACILLUS, MTB COMPLEX DNA, PCRAFBPCRAFBPCRPCR
MTB Complex DNA by PCR   Not detected
 This assay is performed using the
 Amplicor MTB test manufactured &
 distributed by Roche Diagnostics
 Systems, Inc. It is a target amplified
 in vitro diagnostic test for the
 qualitative detection of M. tuberculosis
 complex DNA in concentrated sediments
 prepared from sputum (induced/
 expectorated), bronchial specimens
 including bronchial alveolar lavages
 and aspirates, or tracheal aspirates.
 The MTB test is intended for use as an
 adjunctive test for evaluating acid-
 fast bacilli smear positive sediments
 from untreated patients suspected of
 having tuberculosis. It is specific
 for, but does not differentiate among,
 members of the M. tuberculosis complex,
 i.e., M. tuberculosis, M. bovis,
 M. bovis BCG, M africanum, & M. micoti.
 A negative test result does not exclude
 the possibility of isolating a M.
 tuberculosis complex organism from the
 specimen. The manufacturer has not
 determined the efficacy of this test
 for the detection of M. tuberculosis
 from non-respiratory specimens. The 
 performance characteristics of the
 test on non-respiratory specimens
 have been determined by Focus
 Technologies.
ACID HEMOLYSIS (HAM TEST)HAMMHAMVisual
Acid Hemolysin      Negative
Sucrose Lysis       Negative
ACID MUCOPOLYSACCHARIDES, URINEACID MPSMPSURColorimetric
Acid Mucopolysaccharides, 
 Urine                LT 70           mg/L
Creatinine, Urine                     mg/dL
Acid MPS (calc)       LT 100          mg/gCr
MPS Interp
ACID PHOSPHATASE WITH TARTRATE STAINSS.TRAPTRAPCytochemical Stain; TRAP Stain
Source
Tartrate Resistant Acid Phosphatase Stain
TRAP Interpretation
Reviewed by
ACID PHOSPHATASE TOTALACPTQACPTQEnzymatic
Acid Phosphatae Total   3.1-7.0   U/L
ACTIVATED PROTEIN C RESISTANCEAPCRESAPCRClot-based Assay
APC Resistance
 Normal  GT 2.0 ratio
ACYLCARNITINES, QUANTITATIVEACYQUTACYQUTMS/MS
Acetylcarnitine, C:2                 nmol/mL
 1-7 days        2.14-15.89
 8 days-7 years  2.00-27.57
 8 yrs & older   2.00-17.83
Propionylcarnitine, C3               nmol/mL
 1-7 days        LT 0.55
 8 days-7 years  LT 1.78
 8 yrs & older   LT 0.88
Iso-/Butyrylcarnitine, C4            nmol/mL
 1-7 days        LT 0.46m
 8 days-7 years  LT 1.06
 8 yrs & older   LT 0.83
Isovaleryl-/2-Methylbutyrylcarnitine nmol/mL
 C5
 1-7 days        LT 0.38
 8 days-7 years  LT 0.63
 8 yrs & older   LT 0.51
Hexanoylcarnitine, C6                nmol/mL
 1-7 days        LT 0.14
 8 days-7 years  LT 0.23
 8 yrs & older   LT 0.17
3-OH-hexanoylcarnitine, C6-OH        nmol/mL
 1-7 days        LT 0.08
 8 days-7 years  LT 0.19
 8 yrs & older   LT 0.09
Octenoylcarnitine, C8:1              nmol/mL
 1-7 days        LT 0.48
 8 days-7 years  LT 0.91
 8 yrs & older   LT 0.88
Octanoylcarnitine, C8                nmol/mL
 1-7 days        LT 0.19
 8 days-7 years  LT 0.45
 8 yrs & older   LT 0.78
Decenoylcarnitine, C10:1             nmol/mL
 1-7 days        LT 0.25
 8 days-7 years  LT 0.46
 8 yrs & older   LT 0.47
Decanoylcarnitine, C10               nmol/mL
 1-7 days        LT 0.27
 8 days-7 years  LT 0.91
 8 years & older LT 0.88
Glutarylcarnitine, C5-DC             nmol/mL
 1-7 days        LT 0.06
 8 days-7 years  LT 0.10
 8 yrs & older   LT 0.11
Dodecenoylcarnitine, C12:1           nmol/mL
 1-7 days        LT 0.19
 8 days-7 years  LT 0.37
 8 yrs & older   LT 0.35
Dodecanoylcarnitine, C12             nmol/mL
 1-7 days        LT 0.18
 8 days-7 years  LT 0.35
 8 yrs & older   LT 0.26
3-OH-dodecanoylcarnitine, C12-OH     nmol/mL
 1-7 days        LT 0.06
 8 days-7 years  LT 0.09
 8 yrs & older   LT 0.26
Tetradecadienoylcarnitine, C14:2     nmol/mL
 1-7 days        LT 0.09
 8 days-7 years  LT 0.13
 8 yrs & older   LT 0.18
Tetradecenoylcarnitine, C14:1        nmol/mL
 1-7 days        LT 0.16
 8 days-7 years  LT 0.35
 8 yrs & older   LT 0.24
Tetradecanoylcarnitine, C14          nmol/mL
 1-7 days        LT 0.11
 8 days-7 years  LT 0.15
 8 yrs & older   LT 0.12
3-OH-tetradecenoylcarnitine,         nmol/mL
 C14:1-OH
 1-7 days        LT 0.06
 8 days-7 years  LT 0.18
 8 yrs & older   LT 0.13
3-OH-tetradecanoylcarnitine, C14-OH  nmol/mL
 1-7 days        LT 0.04
 8 days-7 years  LT 0.05
 8 yrs & older   LT 0.08
Hexadecenoylcarnitine, C16:1         nmol/mL
 1-7 days        LT 0.15
 8 days-7 years  LT 0.21
 8 yrs & older   LT 0.10
Hexadecanoylcarnitine, C16           nmol/mL
 1-7 days        LT 0.36
 8 days-7 years  LT 0.52
 8 yrs & older   LT 0.23
3-OH-hexadecenoylcarnitine, C16:1-OH nmol/mL
 1-7 days        LT 0.78
 8 days-7 years  LT 0.36
 8 yrs & older   LT 0.06
3-OH-hexadecanoylcarnitine, C16-OH   nmol/mL
 1-7 days        LT 0.10
 8 days-7 years  LT 0.07
 8 yrs & older   LT 0.06
Linoleylcarnitine, C18:2             nmol/mL
 1-7 days        LT 0.12
 8 days-7 years  LT 0.31
 8 yrs & older   LT 0.24
Oleylcarnitine, C18:1                nmol/mL
 1-7 days        LT 0.25
 8 days-7 years  LT 0.45
 8 yrs & older   LT 0.39
Stearoylcarnitine, C18               nmol/mL
 1-7 days        LT 0.10
 8 days-7 years  LT 0.12
 8 yrs & older   LT 0.14
3-OH-linoleylcarnitine, C18:2-OH     nmol/mL
 1-7 days        LT 0.04
 8 days-7 years  LT 0.06
 8 yrs & older   LT 0.06
3-OH-oleylcarnitine, C18:1-OH        nmol/mL
 1-7 days        LT 0.03
 8 days-7 years  LT 0.04
 8 yrs & older   LT 0.06
Comment
ADENOSINE DEAMINASE, BODY FLUIDshipping instruction codeADEDFLADEDFLSpectrophotometry
Adenosine Deaminase, Body Fluid     U/L
 Pleural transudate (total protein
 LT 3.0 g/dL)   0.0-6.7
 Pleural exudate (total protein GT
 3.0 g/dL)      1.6-9.2
 Tuberculosis   19.0-85.0
 Neoplastic     0.0-22.0
 Pneumonia      0.0-19.0
 RA             23.0-42.0
 Lymphoma       6.0-420.0
 Peritoneal exudate or transudate
 CSF            LT 10.0
ADENOSINE DEAMINASE, RBCADA.RBCADARBCSpectrophotometry
Adenosine Deaminase, RBC  0.6-1.8 U/gHgb
ADENOVIRUS ANTIBODY, IGG & IGMADENGMADENGMELISA
Adenovirus Antibody, IgG          IV
 0.89 or less      Negative-no significant
 level of adenovirus IgG antibody
 detected.
 0.90-1.10         Equivocal-questionable
 presence of adenovirus IgG antibody
 detected. Repeat testing in 10-14 
 days may be helpful.
 1.11 or more      Positive-IgG antibody
 to adenovirus detected, which may
 suggest current or past infection.
Adenovirus Antibody, IgM          IV
 0.89 or less      Negative-no significant
 level of adenovirus IgM antibody
 detected.
 0.90-1.10         Equivocal-questionable
 presence of adenovirus IgM antibody
 detected. Repeat testing in 10-14 
 days may be helpful.
 1.11 or more      Positive-IgM antibody
 to adenovirus detected, which may
 suggest current or recent infection.
ADRENAL ANTIBODY, (REFLEXIVE)ADREABADREABIFA
Adrenal Antibody        Negative in normal
                        individuals
Adrenal Antibody, Titer                    Titer
ADRENOCORTICOTROPIC HORMONE ASSAYACTHACTHChemiluminesence DPC Immulite
ACTH    0-46             pg/mL
 Adults drawn between 0700 and
 1000 AM
ALBUMINALBALBColorimetric
Albumin                 g/dL
 0-4 days        2.9-4.6 
 4 days-14 yrs   3.9-5.6
 14-18 yrs       3.3-4.7
 18-60 yrs       3.5-5.0
 60-90 yrs       3.3-4.8
 90 yrs+         3.0-4.7
ALBUMIN, CSFALB-CALBSFNephelometry
Albumin, CSF  5-30  mg/dL
ALBUMIN, FLUIDALBFLALBFLColorimetric
Albumin, Fluid             g/dL
 No normals established
ALBUMIN, GLYCATEDGLYCOALBUMINGLYALBTurbidimetric Immunoassay
Albumin, Glycated    0.6-3.0   %
ALDOLASEALDOLASEALDEnzymatic
Aldolase     U/L
 M 2.0-7.0  
 F 1.0-8.0
ALDOSTERONE, SERUMALDOSTERONEALDOSRIA
Aldosterone        ng/dL
 Standing   4-31    
 Recumbent  1-16
ALDOSTERONE, URINEALDOSTERONE-UALDUQ
Collection Period                    h
Volume                               mL
Aldosterone, Urine
 Normal diet     6-25                ug/d
 Low salt diet   17-44
 High salt diet  0-6
 Normal urine values of aldosterone
 Normal sodium intake  100-200       mEq 
 Low sodium intake     LT 25         mEq 
 High sodium intake    GT 200        mEq  
Creatinine, Urine                    mg/dL
Creatinine, Urine                    mg/d                              
 M 0-2 yrs     Not established
   3-8 yrs     140-700
   9-12 yrs    300-1300
   13-17 yrs   500-2300
   18-50 yrs   1000-2500
   51-80 yrs   800-2100
   81+ yrs     600-2000
 F 0-2 yrs     Not established
   3-8 yrs     140-700
   9-12 yrs    300-1300
   13-17 yrs   400-1600
   18-50 yrs   700-1600
   51-80 yrs   500-1400
   81+ yrs     400-1300
ALDOSTERONE/RENIN RATIOALDRENALDRENRIA
Aldosterone                     ng/dL
 Standing               4-31    
 Recumbent              1-16
Renin                           ng/mL/h
 (With unrestricted salt intake)
 Random Ambulatory      0.8-2.5 
 Random Non-ambulatory  1.5-5.2
Aldosterone/Renin Ratio
 An Aldosterone/Renin activity ratio
 of GT 25 is suggestive of
 hyperaldosteronism.
ALKALINE PHOSPHATASEAKPALKPColorimetric
Alkaline Phosphatase        U/L
 0-6 yrs        72-307  
 6-9 yrs        133-340
 9-15 yrs  M    103-429
 15-18 yrs M    49-210
 9-13 yrs  F    99-453
 13-15 yrs F    53-186
 15-18 yrs F    38-110
 18 yrs+        38-110
ALKALINE PHOSPHATASE ISOENZYMES (HEAT STABLE)AKP-ISOAKPISOColor w/ Heat Fract
Alkaline Phosphatase                 U/L
 0-6 yrs      72-307
 6-9 yrs      133-340
 9-15 yrs  M  103-429
 15-18 yrs M  49-210
 9-13 yrs  F  99-453
 13-15 yrs F  53-186
 15-18 yrs F  38-110
 18 yrs+      38-110
Alkaline Phos, Heat Stable 30-85     U/L
Alkaline Phos, % Heat Stable         %
 LT 20% heat stable activity indicates
 a predominance of bone isoenzyme.
 25-55% heat stable activity suggests
 a predominance of liver and/or in-
 testinal isoenzyme.
 GT 25% heat stable activity in a 
 patient with an elevated GGT
 indicates a predominance of liver
 isoenzyme.
ALKALINE PHOSPHATASE, BONE SPECIFICALKPBSALKPBSICMA
Alkaline Phosphatase, Bone Specific  ug/L
 F 7-9 yrs          36.3-159.4
   10-12 yrs        44.2-163.3
   13-15 yrs        14.8-136.2
   16-17 yrs        10.5-44.8
   Premenopausal    4.5-16.9
   Postmenopausal   7.0-22.4
 M 7-9 yrs          48.6-140.4
   10-12 yrs        48.8-155.5
   13-15 yrs        27.8-210.9
   16-17 yrs        15.3-126.8
   18-24 yrs        not established
   25 yrs & older   6.5-20.1
ALLERGEN, ACREMONIUM KILIENSE, IGEICMCPICMCPFEIA
Acremonium Kiliense, IgE     LT 0.35    kU/L
ALLERGEN, ACACIA TREE, IGEICTACICTACFEIA
Acacia Tree, IgE     LT 0.35    kU/L
ALLERGEN, ALMOND, IGEICFALICFALFEIA
Almond, IgE     LT 0.35    kU/L
ALLERGEN, ALPHA-LACTALBUMIN [ARUP]ICALARICALARImmunocap
Alpha-Lactalbumin, IgE     LT 0.35          kU/L
ALLERGEN, ALTERNARIA TENUIS (ALTERNATA), IGEICMALICMALFEIA
Alternaria Tenuis (Alternata), IgE     LT 0.35    kU/L
ALLERGEN, AMERICAN BEECH TREE, IGEICTABICTABFEIA
American Beech Tree, IgE     LT 0.35    kU/L
ALLERGEN, APPLE, IGEICFAPICFAPFEIA
Apple, IgE     LT 0.35    kU/L
ALLERGEN, APRICOT IGE (ARUP)ICAPARICAPARIMMUNOCAP
Apricot, IgE     LT 0.35   kU/L
ALLERGEN, ASPERGILLUS FUMIGATUS, IGEICMAFICMAFFEIA
Aspergillus Fumigatus, IgE     LT 0.35    kU/L
ALLERGEN, ASPERGILLUS NIGER, IGEICMANICMANFEIA
Aspergillus Niger, IgE     LT 0.35    kU/L
ALLERGEN, AUREOBASIDIUM PULLULANS (PULLULARIA), IGEICMPUICMPUFEIA
Aureobasidium Pullulans (Pullularia), IgE     LT 0.35    kU/L
ALLERGEN, AVACADO [ARUP]ICAVARICAVARImmunocap
Avacado, IgE     LT 0.35          kU/L
ALLERGEN, BANANA, IGEICFBNICFBNFEIA
Banana, IgE     LT 0.35    kU/L
ALLERGEN, BARLEY, IGEICFBAICFBAFEIA
Barley, IgE     LT 0.35    kU/L
ALLERGEN, BEEF, IGEICFBFICFBFFEIA
Beef, IgE     LT 0.35    kU/L
ALLERGEN, BENTGRASS, IGEICGBGICGBGFEIA
Bentgrass, IgE     LT 0.35    kU/L
ALLERGEN, BERMUDA GRASS, IGEICGBMICGBMFEIA
Bermuda Grass, IgE     LT 0.35    kU/L
ALLERGEN, BLUE MUSSEL [ARUP]ICBMARICBMARImmunocap
Blue Mussel, IgE     LT 0.35          kU/L
ALLERGEN, BOX ELDER, IGEICTBEICTBEFEIA
Box Elder, IgE     LT 0.35    kU/L
ALLERGEN, BRAZIL NUT, IGEICFBZICFBZFEIA
Brazil Nut, IgE     LT 0.35    kU/L
ALLERGEN, BROCCOLI, IGEICFBRICFBRFEIA
Broccoli, IgE     LT 0.35    kU/L
ALLERGEN, BROME GRASS, IGEICGBRICGBRFEIA
Brome Grass, IgE     LT 0.35    kU/L
ALLERGEN, CABBAGE [ARUP]ICCAARICCAARImmunocap
Cabbage, IgE     LT 0.35          kU/L
ALLERGEN, CANDIDA ALBICANS, IGEICMCAICMCAFEIA
Candida Albicans, IgE     LT 0.35    kU/L
ALLERGEN, CARROT, IGEICFCAICFCAFEIA
Carrot, IgE     LT 0.35    kU/L
ALLERGEN, CASEIN, IGEICFCSICFCSFEIA
Casein, IgE     LT 0.35    kU/L
ALLERGEN, CASEIN, IGGCASIGGCASIGGEIA
Allergen, Casein, IgG   LT 10.0    ug/mL
 Score        Concentration     Interp
   0              LT 10.0       Undetectable or
                                very low antibody
                                levels
   1              10.0-15.0     Low antibody levels

   2              15.1-20.0     Moderate antibody 
                                levels
   3              20.1-50.0     High antibody levels
   4              50.1-100.0    Very high antibody
                                levels
   5              GT 100.0      Extremely high antibody
                                levels
ALLERGEN, CASEIN, IGG4CASIG4CASIG4EIA
Allergen, Casein, IgG4   LT 10.0    ug/mL
 Score        Concentration     Interp
   0              LT 2.0       Insignificant IgG4
                               level
   1              2.0-5.4      Equivocal
   2              5.5-14.1     Low antibody level
   3              14.2-22.7    Moderate antibody level
   4              22.8-31.3    Mod/high antibody level
   5              31.4-39.9    High antibody level
   6              40.0 or more Extermely high antibody
                               level
 Interpretation for patients undergoing immunotherapy
  LT 2.0      Normal, non-atopic subject
  2.0-5.4     Untreated atopic subject
  5.5-40.0+   Indicated increasing levels of antibody
                                levels
ALLERGEN, CASHEW NUT, IGEICFCWICFCWFEIA
Cashew Nut, IgE     LT 0.35    kU/L
ALLERGEN, CAT DANDER, IGEICECEICECEFEIA
Cat Dander, IgE     LT 0.35    kU/L
ALLERGEN, CELERY [ARUP]ICCEARICCEARImmunocap
Celery, IgE     LT 0.35          kU/L
ALLERGEN, CHEESE, CHEDDAR TYPE, IGEICFCCICFCCFEIA
Cheese, Cheddar Type, IgE     LT 0.35    kU/L
ALLERGEN, CHEESE, MOLD TYPE, IGEICFMCICFMCFEIA
Cheese, Mold Type, IgE     LT 0.35    kU/L
ALLERGEN, CHERRY [IBT]ICCHIICCHIFEIA
Cherry, IgE     LT 0.35          kU/L
ALLERGEN, CHICKEN MEAT, IGEICFCKICFCKFEIA
Chicken Meat, IgE     LT 0.35    kU/L
ALLERGEN, CHICKPEA [ARUP]ICCPARICCPARImmunocap
Chickpea, IgE     LT 0.35          kU/L
ALLERGEN, CHOCOLATE/CACAO, IGEICFCHICFCHFEIA
Chocolate/Cacao, IgE     LT 0.35    kU/L
ALLERGEN, CINNAMON, IGEICFCIICFCIFEIA
Cinnamon, IgE     LT 0.35    kU/L
ALLERGEN, CLADOSPORIUM HERBARUM, IGEICMCHICMCHFEIA
Cladosporium Herbarum, IgE     LT 0.35    kU/L
ALLERGEN, CLAM, IGEICFCLICFCLFEIA
Clam, IgE     LT 0.35    kU/L
ALLERGEN, COCKLEBUR, IGEICWCBICWCBFEIA
Cocklebur, IgE     LT 0.35    kU/L
ALLERGEN, COCKROACH, IGEICICRICICRFEIA
Cockroach, IgE     LT 0.35    kU/L
ALLERGEN, COCONUT [ARUP]ICCNARICCNARImmunocap
Coconut, IgE     LT 0.35          kU/L
ALLERGEN, CODFISH (WHITEFISH), IGEICFCDICFCDFEIA
Codfish (Whitefish), IgE     LT 0.35    kU/L
ALLERGEN, COMMON SILVER BIRCH , IGEICTBRICTBRFEIA
Common Silver Birch, IgE     LT 0.35    kU/L
ALLERGEN, CORN (MAIZE), IGEICFCNICFCNFEIA
Corn (Maize), IgE     LT 0.35    kU/L
ALLERGEN, CORN, IGGCRNIGGCRNIGGEIA
Allergen, Corn, IgG   LT 10.0    ug/mL
 Score        Concentration     Interp
   0              LT 10.0       Undetectable or
                                very low antibody
                                levels
   1              10.0-15.0     Low antibody levels

   2              15.1-20.0     Moderate antibody 
                                levels
   3              20.1-50.0     High antibody levels
   4              50.1-100.0    Very high antibody
                                levels
   5              GT 100.0      Extremely high antibody
                                levels
ALLERGEN, CORN, IGG4CRNIG4CRNIG4EIA
Allergen, Corn, IgG4   LT 10.0    ug/mL
 Score        Concentration     Interp
   0              LT 2.0       Insignificant IgG4
                               level
   1              2.0-5.4      Equivocal
   2              5.5-14.1     Low antibody level
   3              14.2-22.7    Moderate antibody level
   4              22.8-31.3    Mod/high antibody level
   5              31.4-39.9    High antibody level
   6              40.0 or more Extermely high antibody
                               level
 Interpretation for patients undergoing immunotherapy
  LT 2.0      Normal, non-atopic subject
  2.0-5.4     Untreated atopic subject
  5.5-40.0+   Indicated increasing levels of antibody
                                levels
ALLERGEN, COTTONWOOD TREE, IGEICTCWICTCWFEIA
Cottonwood Tree, IgE     LT 0.35    kU/L
ALLERGEN, COW DANDER, IGEICECDICECDFEIA
Cow Dander, IgE     LT 0.35    kU/L
ALLERGEN, COW'S MILK, IGEICFCMICFCMFEIA
Cow's Milk, IgE     LT 0.35    kU/L
ALLERGEN, CRAB, IGEICFCRICFCRFEIA
Crab, IgE     LT 0.35    kU/L
ALLERGEN, CULTIVATED OAT, IGEICGCOICGCOFEIA
Cultivated Oat, IgE     LT 0.35    kU/L
ALLERGEN, D. FARINAE (MITE), IGEICDM2ICDM2FEIA
D. farinae (Mite), IgE     LT 0.35    kU/L
ALLERGEN, D. PTERONYSSINUS (MITE), IGEICDM1ICDM1FEIA
D. pteronyssinus (Mite), IgE     LT 0.35    kU/L
ALLERGEN, DOG DANDER, IGEICEDDICEDDFEIA
Dog Dander, IgE     LT 0.35    kU/L
ALLERGEN, DOG EPITHELIUM, IGEICEDEICEDEFEIA
Dog Epithelium, IgE     LT 0.35    kU/L
ALLERGEN, EGG WHITE, IGEICFEWICFEWFEIA
Egg White, IgE     LT 0.35    kU/L
ALLERGEN, EGG WHOLE, IGEICFEGICFEGFEIA
Egg Whole, IgE     LT 0.35    kU/L
ALLERGEN, EGG WHOLE, IGGWEIGGWEIGGEIA
Allergen, Whole Egg, IgG   LT 10.0                ug/mL
 Score        Concentration     Interp
   0              LT 10.0       Undetectable or
                                very low antibody
                                levels
   1              10.0-15.0     Low antibody levels

   2              15.1-20.0     Moderate antibody 
                                levels
   3              20.1-50.0     High antibody levels
   4              50.1-100.0    Very high antibody
                                levels
   5              GT 100.0      Extremely high antibody
                                levels
ALLERGEN, EGG WHOLE, IGG4WEIG4WEIG4EIA
Allergen, Egg, Whole, IgG4   LT 10.0                    ug/mL
 Score        Concentration     Interp
   0              LT 2.0       Insignificant IgG4
                               level
   1              2.0-5.4      Equivocal
   2              5.5-14.1     Low antibody level
   3              14.2-22.7    Moderate antibody level
   4              22.8-31.3    Mod/high antibody level
   5              31.4-39.9    High antibody level
   6              40.0 or more Extermely high antibody
                               level
 Interpretation for patients undergoing immunotherapy
  LT 2.0      Normal, non-atopic subject
  2.0-5.4     Untreated atopic subject
  5.5-40.0+   Indicated increasing levels of antibody
                                levels
ALLERGEN, EGG YOLK, IGEICFEYICFEYFEIA
Egg Yolk, IgE     LT 0.35    kU/L
ALLERGEN, ELM TREE, IGEICTELICTELFEIA
Elm Tree, IgE     LT 0.35    kU/L
ALLERGEN, ENGLISH PLANTAIN (RIBWORT), IGEICWEPICWEPFEIA
English Plantain (Ribwort), IgE     LT 0.35    kU/L
ALLERGEN, EUCALYPTUS (GUM) TREE, IGEICTEUICTEUFEIA
Eucalyptus (Gum) Tree, IgE     LT 0.35    kU/L
ALLERGEN, FALSE RAGWEED, IGEICWFRICWFRFEIA
False Ragweed, IgE     LT 0.35    kU/L
ALLERGEN, GARLIC, IGEICFGAICFGAFEIA
Garlic, IgE     LT 0.35    kU/L
ALLERGEN, GIANT RAGWEED, IGEICWGRICWGRFEIA
Giant Ragweed, IgE     LT 0.35    kU/L
ALLERGEN, GINGER [IBT]ICGINTICGINTFEIA
Ginger, IgE     LT 0.35          kU/L
ALLERGEN, GLUTEN, IGEICFGTICFGTFEIA
Gluten, IgE     LT 0.35    kU/L
ALLERGEN, GLUTEN, IGGGLNIGGGLNIGGEIA
Allergen, Gluten, IgG   LT 10.0    ug/mL
 Score        Concentration     Interp
   0              LT 10.0       Undetectable or
                                very low antibody
                                levels
   1              10.0-15.0     Low antibody levels

   2              15.1-20.0     Moderate antibody 
                                levels
   3              20.1-50.0     High antibody levels
   4              50.1-100.0    Very high antibody
                                levels
   5              GT 100.0      Extremely high antibody
                                levels
ALLERGEN, GLUTEN, IGG4GLNIG4GLNIG4EIA
Allergen, Gluten, IgG4   LT 10.0    ug/mL
 Score        Concentration     Interp
   0              LT 2.0       Insignificant IgG4
                               level
   1              2.0-5.4      Equivocal
   2              5.5-14.1     Low antibody level
   3              14.2-22.7    Moderate antibody level
   4              22.8-31.3    Mod/high antibody level
   5              31.4-39.9    High antibody level
   6              40.0 or more Extermely high antibody
                               level
 Interpretation for patients undergoing immunotherapy
  LT 2.0      Normal, non-atopic subject
  2.0-5.4     Untreated atopic subject
  5.5-40.0+   Indicated increasing levels of antibody
                                levels
ALLERGEN, GOLDENROD, IGEICWGDICWGDFEIA
Goldenrod, IgE     LT 0.35    kU/L
ALLERGEN, GOOSE FEATHERS, IGEICEGFICEGFFEIA
Goose Feathers, IgE     LT 0.35    kU/L
ALLERGEN, GRAPE (RAISIN), IGEICFGRICFGRFEIA
Grape (Raisin), IgE     LT 0.35    kU/L
ALLERGEN, GREY ALDER TREE, IGEICTALICTALFEIA
Grey Alder Tree, IgE     LT 0.35    kU/L
ALLERGEN, HALIBUT [ARUP]ICHBARICHBARImmunocap
Halibut, IgE     LT 0.35          kU/L
ALLERGEN, HAZEL NUT (FILBERT), IGEICFHZICFHZFEIA
Hazel Nut (Filbert), IgE     LT 0.35    kU/L
ALLERGEN, HAZEL NUT TREE, IGEICTHZICTHZFEIA
Hazel Nut Tree, IgE     LT 0.35    kU/L
ALLERGEN, HONEYBEE VENOM, IGEICIHBICIHBFEIA
Honeybee Venom, IgE     LT 0.35    kU/L
ALLERGEN, HORSE DANDER, IGEICEHHICEHHFEIA
Horse Dander, IgE     LT 0.35    kU/L
ALLERGEN, HOUSE DUST (GREER), IGEICHDGICHDGFEIA
House Dust (Greer), IgE     LT 0.35    kU/L
ALLERGEN, HOUSE DUST (HOLLISTER-STEIR), IGEICHDSICHDSFEIA
House Dust (Hollister-Steir), IgE     LT 0.35    kU/L
ALLERGEN, JAPANESE CEDAR, IGEICTRWICTRWFEIA
Japanese Cedar, IgE     LT 0.35    kU/L
ALLERGEN, JOHNSON GRASS, IGEICGJOICGJOFEIA
Johnson Grass, IgE     LT 0.35    kU/L
ALLERGEN, KIWI [ARUP]ICKIARICKIARImmunocap
Kiwi, IgE     LT 0.35          kU/L
ALLERGEN, KOCHIA (FIREBUSH), IGEICWKOICWKOFEIA
Kochia (Firebush), IgE     LT 0.35    kU/L
ALLERGEN, LAMB'S QUARTERS (GOOSEFOOT), IGEICWLQICWLQFEIA
Lamb's Quarters (Goosefoot), IgE     LT 0.35    kU/L
ALLERGEN, LATEX (BRAZILIAN RUBBER TREE), IGEICOLTICOLTFEIA
Latex (Brazilian Rubber Tree), IgE     LT 0.35    kU/L
ALLERGEN, LENTIL [ARUP]ICLTARICLTARImmunocap
Lentil, IgE     LT 0.35          kU/L
ALLERGEN, LETTUCE, IGEICFLEICFLEFEIA
Lettuce, IgE     LT 0.35    kU/L
ALLERGEN, LIMA BEAN/WHITE BEAN [ARUP]ICLBARICLBARImmunocap
Lima Bean/White Bean, IgE     LT 0.35          kU/L
ALLERGEN, LOBSTER, IGEICFLBICFLBFEIA
Lobster, IgE     LT 0.35    kU/L
ALLERGEN, MACADAMIA NUT, IGEICFMDICFMDFEIA
Macadamia Nut, IgE     LT 0.35    kU/L
ALLERGEN, MALT, IGEICFMLICFMLFEIA
Malt, IgE     LT 0.35    kU/L
ALLERGEN, MANGO [ARUP]ICMAARICMAARImmunocap
Mango, IgE     LT 0.35          kU/L
ALLERGEN, MAPLE LEAF SYCAMORE TREE, IGEICTSYICTSYFEIA
Maple Leaf Sycamore Tree, IgE     LT 0.35    kU/L
ALLERGEN, MEADOW (KENTUCKY BLUE) GRASS, IGEICGKBICGKBFEIA
Meadow (Kentucky Blue) Grass, IgE     LT 0.35    kU/L
ALLERGEN, MEADOW FESCUE, IGEICGMFICGMFFEIA
Meadow Fescue, IgE     LT 0.35    kU/L
ALLERGEN, MELON, IGEICFWMICFWMFEIA
Melon, IgE     LT 0.35    kU/L
ALLERGEN, MOUNTAIN CEDAR (JUNIPER) TREE, IGEICTMCICTMCFEIA
Mountain Cedar (Juniper) Tree, IgE     LT 0.35    kU/L
ALLERGEN, MUCOR RACEMOSUS, IGEICMMRICMMRFEIA
Mucor Racemosus, IgE     LT 0.35    kU/L
ALLERGEN, MUGWORT, IGEICWMWICWMWFEIA
Mugwort, IgE     LT 0.35    kU/L
ALLERGEN, MULBERRY TREE, IGEICTMLICTMLFEIA
Mulberry Tree, IgE     LT 0.35    kU/L
ALLERGEN, MUSHROOM [ARUP]ICMUARICMUARImmunocap
Mushroom, IgE     LT 0.35          kU/L
ALLERGEN, MUSTARD, IGEICFMSICFMSFEIA
Mustard, IgE     LT 0.35    kU/L
ALLERGEN, NETTLE, IGEICWNTICWNTFEIA
Nettle, IgE     LT 0.35    kU/L
ALLERGEN, OAK TREE, IGEICTOKICTOKFEIA
Oak Tree, IgE     LT 0.35    kU/L
ALLERGEN, OAT, IGEICFOTICFOTFEIA
Oat, IgE     LT 0.35    kU/L
ALLERGEN, OLIVE TREE, IGEICTOLICTOLFEIA
Olive Tree, IgE     LT 0.35    kU/L
ALLERGEN, ONION, IGEICFONICFONFEIA
Onion, IgE     LT 0.35    kU/L
ALLERGEN, ORANGE, IGEICFOGICFOGFEIA
Orange, IgE     LT 0.35    kU/L
ALLERGEN, ORCHARD GRASS (COCKSFOOT), IGEICGOGICGOGFEIA
Orchard Grass (Cocksfoot), IgE     LT 0.35    kU/L
ALLERGEN, OYSTER, IGEICFOYICFOYFEIA
Oyster, IgE     LT 0.35    kU/L
ALLERGEN, PAPER WASP VENOM, IGEICIPWICIPWFEIA
Paper Wasp Venom, IgE     LT 0.35    kU/L
ALLERGEN, PARSLEY [ARUP]ICPLARICPLARImmunocap
Parsley, IgE     LT 0.35          kU/L
ALLERGEN, PEA, GREEN, IGEICFGPICFGPFEIA
Pea, Green, IgE     LT 0.35    kU/L
ALLERGEN, PEACH [IBT]ICPCIICPCIFEIA
Peach, IgE     LT 0.35          kU/L
ALLERGEN, PEANUT, IGEICFPNICFPNFEIA
Peanut, IgE     LT 0.35    kU/L
ALLERGEN, PEAR, IGEICFPRICFPRFEIA
Pear, IgE     LT 0.35    kU/L
ALLERGEN, PECAN (WHITE HICKORY) TREE, IGEICTPEICTPEFEIA
Pecan (White Hickory) Tree, IgE     LT 0.35    kU/L
ALLERGEN, PECAN NUT, IGEICFPEICFPEFEIA
Pecan Nut, IgE     LT 0.35    kU/L
ALLERGEN, PENICILLIUM CHRYSOGENUM, IGEICMPNICMPNFEIA
Penicillium Chrysogenum, IgE     LT 0.35    kU/L
ALLERGEN, PENICILLOYL G, IGEICDRPICDRPFEIA
Penicilloyl G, IgE     LT 0.35    kU/L
ALLERGEN, PERCH [ARUP]ICPRARICPRARImmunocap
Perch, IgE     LT 0.35          kU/L
ALLERGEN, PERENNIAL RYE GRASS, IGEICGPRICGPRFEIA
Perennial Rye Grass, IgE     LT 0.35    kU/L
ALLERGEN, PIGWEED, IGEICWPGICWPGFEIA
Pigweed, IgE     LT 0.35    kU/L
ALLERGEN, PINE NUT [ARUP]ICNARICNARImmunocap
Pine Nut, IgE     LT 0.35          kU/L
ALLERGEN, PINEAPPLE, IGEICFPAICFPAFEIA
Pineapple, IgE     LT 0.35    kU/L
ALLERGEN, PISTACHIO [ARUP]ICPIARICPIARImmunocap
Pistachio, IgE     LT 0.35          kU/L
ALLERGEN, PORK, IGEICFPKICFPKFEIA
Pork, IgE     LT 0.35    kU/L
ALLERGEN, POTATO (WHITE), IGEICFPTICFPTFEIA
Potato (White), IgE     LT 0.35    kU/L
ALLERGEN, RICE, IGEICFRCICFRCFEIA
Rice, IgE     LT 0.35    kU/L
ALLERGEN, ROUGH MARSH ELDER, IGEICWMEICWMEFEIA
Rough Marsh Elder, IgE     LT 0.35    kU/L
ALLERGEN, RUSSIAN THISTLE (SALTWORT), IGEICWRTICWRTFEIA
Russian Thistle (Saltwort), IgE     LT 0.35    kU/L
ALLERGEN, RYE, IGEICFRYICFRYFEIA
Rye, IgE     LT 0.35    kU/L
ALLERGEN, SALMON, IGEICFSAICFSAFEIA
Salmon, IgE     LT 0.35    kU/L
ALLERGEN, SCALE (LENSCALE), IGEICWSCICWSCFEIA
Scale (Lenscale), IgE     LT 0.35    kU/L
ALLERGEN, SCALLOP [ARUP]ICSCARICSCARImmunocap
Scallop, IgE     LT 0.35          kU/L
ALLERGEN, SESAME SEED [ARUP]ICSSARICSSARImmunocap
Sesame Seed, IgE     LT 0.35          kU/L
ALLERGEN, SETOMELANOMMA ROSTRATA, IGEICMHLICMHLFEIA
Setomelanonna Rostrata, IgE     LT 0.35    kU/L
ALLERGEN, SHEEP SORREL (YELLOW DOCK), IGEICWSOICWSOFEIA
Sheep Sorrel (Yellow Dock), IgE     LT 0.35    kU/L
ALLERGEN, SHORT (COMMON) RAGWEED, IGEICWRGICWRGFEIA
Short (Common) Ragweed, IgE     LT 0.35    kU/L
ALLERGEN, SHRIMP, IGEICFSHICFSHFEIA
Shrimp, IgE     LT 0.35    kU/L
ALLERGEN, SOYBEAN, IGEICFSBICFSBFEIA
Soybean, IgE     LT 0.35    kU/L
ALLERGEN, SPINACH, IGEICFSPICFSPFEIA
Spinach, IgE     LT 0.35    kU/L
ALLERGEN, SQUASH SUMMER IGE [IBT]ICSSIICSSIFEIA
Squash Summer, IgE     LT 0.35          kU/L
ALLERGEN, SQUID [ARUP]ICSQARICSQARImmunocap
Squid, IgE     LT 0.35          kU/L
ALLERGEN, STRAWBERRY, IGEICFSTICFSTFEIA
Strawberry, IgE     LT 0.35    kU/L
ALLERGEN, SWEET POTATO [IBT]ICSPIICSPIFEIA
Sweet Potato, IgE     LT 0.35          kU/L
ALLERGEN, SWEET VERNAL GRASS, IGEICGSVICGSVFEIA
Sweet Vernal Grass, IgE     LT 0.35    kU/L
ALLERGEN, TIMOTHY GRASS, IGEICGTMICGTMFEIA
Timothy Grass, IgE     LT 0.35    kU/L
ALLERGEN, TOMATO, IGEICFTMICFTMFEIA
Tomato, IgE     LT 0.35    kU/L
ALLERGEN, TROUT [ARUP]ICTRARICTRARImmunocap
Trout, IgE     LT 0.35          kU/L
ALLERGEN, TUNA, IGEICFTUICFTUFEIA
Tuna, IgE     LT 0.35    kU/L
ALLERGEN, TURKEY MEAT, IGEICFTRICFTRFEIA
Turkey Meat, IgE     LT 0.35    kU/L
ALLERGEN, WALNUT TREE, IGEICTWLICTWLFEIA
Walnut Tree, IgE     LT 0.35    kU/L
ALLERGEN, WALNUT, IGEICFWLICFWLFEIA
Walnut, IgE     LT 0.35    kU/L
ALLERGEN, WATERMELON [ARUP]ICWTARICWTARImmunocap
Watermelon, IgE     LT 0.35          kU/L
ALLERGEN, WESTERN RAGWEED, IGEICWWRICWWRFEIA
Western Ragweed, IgE     LT 0.35    kU/L
ALLERGEN, WHEAT, IGEICFWTICFWTFEIA
Wheat, IgE     LT 0.35    kU/L
ALLERGEN, WHITE ASH TREE [ARUP]ICWAARICWAARImmunocap
White Ash Tree, IgE     LT 0.35          kU/L
ALLERGEN, WHITE PINE TREE, IGEICTWPICTWPFEIA
White Pine Tree, IgE     LT 0.35    kU/L
ALLERGEN, WHITE-FACED HORNET VENOM, IGEICIWFICIWFFEIA
White-faced Hornet Venom, IgE     LT 0.35    kU/L
ALLERGEN, WHITE/NAVY BEAN, IGEICFWBICFWBFEIA
White/Navy Bean, IgE     LT 0.35    kU/L
ALLERGEN, WORM WOOD (SAGEBRUSH), IGEICWSGICWSGFEIA
Worm Wood (Sagebrush), IgE     LT 0.35    kU/L
ALLERGEN, YEAST (BAKERS OR BREWERS), IGEICFBYICFBYFEIA
Yeast (Bakers or Brewers), IgE     LT 0.35    kU/L
ALLERGEN, YELLOW JACKET VENOM, IGEICIYJICIYJFEIA
Yellow Jacket Venom, IgE     LT 0.35    kU/L
ALLERGEN, YELLOW-FACED HORNET VENOM, IGEICIYFICIYFFEIA
Yellow-faced Hornet Venom, IgE     LT 0.35    kU/L
ALLERGENS, 32SCRN32SCRN32FEIA
D. farinae (Mite), IgE     LT 0.35 kU/L
D. pteronyssinus (Mite),   LT 0.35 kU/L
 IgE
Cat Epithelium, IgE        LT 0.35 kU/L
Dog Dander, IgE            LT 0.35 kU/L
Dog Epithelium, IgE        LT 0.35 kU/L
Goose Feathers, IgE        LT 0.35 kU/L
Horse Dander, IgE          LT 0.35 kU/L
Bermuda Grass, IgE         LT 0.35 kU/L
Johnson Grass, IgE         LT 0.35 kU/L
Perennial Rye Grass, IgE   LT 0.35 kU/L
Timothy Grass, IgE         LT 0.35 kU/L
Aspergillus fumigatus, IgE LT 0.35 kU/L
Alternaria tenuis, IgE     LT 0.35 kU/L
Cladosporium herbarum, IgE LT 0.35 kU/L
Acremonium kiliense,       LT 0.35 kU/L
 IgE
Setomelanomma rostrata,    LT 0.35 kU/L
 IgE
Penicillium chrysogenum,   LT 0.35 kU/L
Acacia Tree, IgE           LT 0.35 kU/L
Elm Tree, IgE              LT 0.35 kU/L
Eucalyptus (Gum) Tree, IgE LT 0.35 kU/L
Mulberry Tree, IgE         LT 0.35 kU/L
Oak Tree, IgE              LT 0.35 kU/L
Olive Tree, IgE            LT 0.35 kU/L
Maple Leaf Sycamore Tree,  LT 0.35 kU/L
 IgE
Walnut Tree, IgE           LT 0.35 kU/L
English Plantain(Ribwort), LT 0.35 kU/L
 IgE
Lambs Quarters(Goosefoot), LT 0.35 kU/L
 IgE
Mugwort, IgE               LT 0.35 kU/L
Pigweed, IgE               LT 0.35 kU/L
Russian Thistle(Saltwort), LT 0.35 kU/L
 IgE
Sheep Sorrel(Yellow Duck), LT 0.35 kU/L
 IgE
Western Ragweed, IgE       LT 0.35 kU/L
ALLERGENS, 37SCRN37SCRN37FEIA
D. farinae (Mite), IgE     LT 0.35 kU/L
Cat Dander, IgE            LT 0.35 kU/L
Dog Dander, IgE            LT 0.35 kU/L
Dog Epithelium, IgE        LT 0.35 kU/L
Goose Feathers, IgE        LT 0.35 kU/L
Horse Dander, IgE          LT 0.35 kU/L
Yeast (Bakers/Brewer), IgE LT 0.35 kU/L
Cows Milk, IgE             LT 0.35 kU/L
Corn (Maize), IgE          LT 0.35 kU/L
Egg White, IgE             LT 0.35 kU/L
Egg Yolk, IgE              LT 0.35 kU/L
Malt, IgE                  LT 0.35 kU/L
Peanut, IgE                LT 0.35 kU/L
Soybean, IgE               LT 0.35 kU/L
Tomato, IgE                LT 0.35 kU/L
Wheat, IgE                 LT 0.35 kU/L
Bermuda Grass, IgE         LT 0.35 kU/L
Johnson Grass, IgE         LT 0.35 kU/L
Perennial Rye Grass, IgE   LT 0.35 kU/L
Timothy Grass, IgE         LT 0.35 kU/L
Aspergillus fumigatus, IgE LT 0.35 kU/L
Alternaria tenuis, IgE     LT 0.35 kU/L
Cladosporium herbarum, IgE LT 0.35 kU/L
Acremonium kiliense,       LT 0.35 kU/L
 IgE
Setomelanonna rostrata,    LT 0.35 kU/L
 IgE
Elm Tree, IgE              LT 0.35 kU/L
Mulberry Tree, IgE         LT 0.35 kU/L
Oak Tree, IgE              LT 0.35 kU/L
Olive Tree, IgE            LT 0.35 kU/L
Maple Leaf Sycamore Tree,  LT 0.35 kU/L
 IgE
Walnut Tree, IgE           LT 0.35 kU/L
English Plantain(Ribwort), LT 0.35 kU/L
 IgE
Lambs Quarters(Goosefoot), LT 0.35 kU/L
 IgE
Mugwort, IgE               LT 0.35 kU/L
Pigweed, IgE               LT 0.35 kU/L
Russian Thistle(Saltwort), LT 0.35 kU/L
 IgE
Western Ragweed, IgE       LT 0.35 kU/L
ALLERGENS, ADULT FOOD PROFILE 23ADFP23ADFP23FEIA
Beef, IgE                 LT 0.35 kU/L
Yeast (Bakers/Brewers),   LT 0.35 kU/L
 IgE
Codfish (Whitefish), IgE  LT 0.35 kU/L
Chocolate/Cacao, IgE      LT 0.35 kU/L
Cinnamon, IgE             LT 0.35 kU/L
Clam, IgE                 LT 0.35 kU/L
Cows Milk, IgE            LT 0.35 kU/L
Corn (Maize), IgE         LT 0.35 kU/L
Egg White, IgE            LT 0.35 kU/L
Garlic, IgE               LT 0.35 kU/L
Pea, Green, IgE           LT 0.35 kU/L
Mustard, IgE              LT 0.35 kU/L
Orange, IgE               LT 0.35 kU/L
Pork, IgE                 LT 0.35 kU/L
Peanut, IgE               LT 0.35 kU/L
Potato (White), IgE       LT 0.35 kU/L
Rice, IgE                 LT 0.35 kU/L
Soybean, IgE              LT 0.35 kU/L
Shrimp, IgE               LT 0.35 kU/L
Tomato, IgE               LT 0.35 kU/L
Tuna, IgE                 LT 0.35 kU/L
Walnut, IgE               Lt 0.35 kU/L
Wheat, IgE                LT 0.35 kU/L
ALLERGENS, FOOD PROFILE 10FOOD10FOOD10FEIA
Egg White, IgE            LT 0.35   kU/L
Cows Milk, IgE            LT 0.35   kU/L
Codfish (Whitefish), IgE  LT 0.35   kU/L
Wheat, IgE                LT 0.35   kU/L
Corn (Maize), IgE         LT 0.35   kU/L
Peanut, IgE               LT 0.35   kU/L
Soybean, IgE              LT 0.35   kU/L
Shrimp, IgE               LT 0.35   kU/L
Walnut, IgE               LT 0.35   kU/L
Clam, IgE                 LT 0.35   kU/L
ALLERGENS, GRASS PROFILE 9GRASS9GRASS9FEIA
Redtop Bentgrass, IgE         LT 0.35 kU/L
Bermuda Grass, IgE            LT 0.35 kU/L
Brome Grass, IgE              LT 0.35 kU/L
Meadow Kentucky Blue Grass,   LT 0.35 kU/L
 IgE 
Meadow Fescue, IgE            LT 0.35 kU/L
Orchard Grass, IgE            LT 0.35 kU/L
Perennial Rye Grass, IgE      LT 0.35 kU/L
Sweet Vernal Grass, IgE       LT 0.35 kU/L
Timothy Grass, IgE            LT 0.35 kU/L

English Plantain (Ribwort),   LT 0.35 kU/L
 IgE
Lamb's quaters (Goosefoot),   LT 0.35 kU/L
 IgE
ALLERGENS, HYMENOPTERA PANELVENOM5VENOM5FEIA
Honeybee Venom, IgE       LT 0.35 kU/L
Paper Wasp Venom, IgE     LT 0.35 kU/L
Whitefaced Hornet Venom,  LT 0.35 kU/L
 IgE
Yellowfaced Hornet Venom, LT 0.35 kU/L
 IgE
Yellow Jacket Venom, IgE  LT 0.35 kU/L
ALLERGENS, INHALANT 9INHAL9INHAL9FEIA
D. farinae (Mite), IgE        LT 0.35 kU/L
Cat Dander, IgE               LT 0.35 kU/L
Dog Epithelium, IgE           LT 0.35 kU/L
Perennial Rye Grass, IgE      LT 0.35 kU/L
Alternaria tenius, IgE        LT 0.35 kU/L
Elm Tree, IgE                 LT 0.35 kU/L
Olive Tree, IgE               LT 0.35 kU/L
English Plantain (Ribwort),   LT 0.35 kU/L
 IgE
Short (Common) Ragweed, IgE   LT 0.35 kU/L
 IgE
ALLERGENS, INLAND NORTHWEST 17INW17INW17FEIA
D. pteronyssinus (Mite), IgE LT 0.35 kU/L
D. farinae (Mite),IgE        LT 0.35 kU/L
Cat Dander, IgE              LT 0.35 kU/L
Dog Dander, IgE              LT 0.35 kU/L
Redtop Bentgrass, IgE        LT 0.35 kU/L
Cockroach, IgE               LT 0.35 kU/L
Alternaria tenuis, IgE       LT 0.35 kU/L
Aspergillus fumigatus, IgE   LT 0.35 kU/L
Cladosporium herbarum, IgE   LT 0.35 kU/L
Grey Alder Tree, IgE         LT 0.35 kU/L
Box Elder, IgE               LT 0.35 kU/L
Common Silver Birch Tree,    LT 0.35 kU/L
 IgE            
Cottonwood Tree, IgE         LT 0.35 kU/L
Oak Tree, IgE                LT 0.35 kU/L
Mugwort, IgE                 LT 0.35 kU/L
Pigweed, IgE                 LT 0.35 kU/L
Russian Thistle(Saltwort),   LT 0.35 kU/L
 IgE
ALLERGENS, INTERMOUNTAIN WEST 14IMW14IMW14FEIA
D. farinae (Mite),IgE      LT 0.35 kU/L
Cat Dander, IgE            LT 0.35 kU/L
Dog Dander, IgE            LT 0.35 kU/L
Redtop Bentgrass, IgE      LT 0.35 kU/L
Bermuda Grass, IgE         LT 0.35 kU/L
Cockroach, IgE             LT 0.35 kU/L
Alternaria tenuis, IgE     LT 0.35 kU/L
Grey Alder Tree, IgE       LT 0.35 kU/L
Box Elder, IgE             LT 0.35 kU/L
Common Silver Birch Tree,  LT 0.35 kU/L
 IgE            
Cottonwood Tree, IgE       Lt 0.35 kU/L
Pigweed, IgE               LT 0.35 kU/L
Mugwort, IgE               LT 0.35 kU/L
Russian Thistle(Saltwort), LT 0.35 kU/L
 IgE
ALLERGENS, MOLD PROFILE 5MOLD5MOLD5FEIA
Alternaria tenius, IgE        LT 0.35 kU/L
Aspergillus fumigatus, IgE    LT 0.35 kU/L
Candida albicans, IgE         LT 0.35 kU/L
Cladosporium herbarum, IgE    LT 0.35 kU/L
Penicillium chrysogenum, IgE  LT 0.35 kU/L
ALLERGENS, NUT PROFILE 6NUT6NUT6FEIA
Almond, IgE               LT 0.35 kU/L
Cashew, IgE               LT 0.35 kU/L
Hazelnut, IgE             LT 0.35 kU/L
Pecan nut, IgE            LT 0.35 kU/L
Peanut, IgE               LT 0.35 kU/L
Walnut, IgE               LT 0.35 kU/L
ALLERGENS, PACIFIC NORTHWEST 14PNW14PNW14FEIA
D. pteronyssinus (Mite),   LT 0.35 kU/L
 IgE
Cat Dander, IgE            LT 0.35 kU/L
Dog Dander, IgE            LT 0.35 kU/L
Timothy Grass, IgE         LT 0.35 kU/L
Cockroach, IgE             LT 0.35 kU/L
Alternaria tenuis, IgE     LT 0.35 kU/L
Grey Alder Tree, IgE       LT 0.35 kU/L
Box Elder, IgE             LT 0.35 kU/L
Common Silver Birch Tree,  LT 0.35 kU/L
 IgE
Oak Tree, IgE              LT 0.35 kU/L
Walnut Tree, IgE           LT 0.35 kU/L
Pigweed, IgE               LT 0.35 kU/L
Russian Thistle(Saltwort), LT 0.35 kU/L
 IgE
Western Ragweed, IgE       LT 0.35 kU/L
ALLERGENS, PEDIATRIC FOOD PROFILE 21PDFP21PDFP21FEIA
Barley, IgE               LT 0.35 kU/L
Banana, IgE               LT 0.35 kU/L
Yeast (Bakers/Brewers),   LT 0.35 kU/L
 IgE
Codfish, IgE              LT 0.35 kU/L
Chocolate/Cacao, IgE      LT 0.35 kU/L
Cows Milk, IgE            LT 0.35 kU/L
Corn (Maize), IgE         LT 0.35 kU/L
Egg White, IgE            LT 0.35 kU/L
Pea, Green, IgE           LT 0.35 kU/L
Orange, IgE               LT 0.35 kU/L
Oat, IgE                  LT 0.35 kU/L
Pork, IgE                 LT 0.35 kU/L
Peanut, IgE               LT 0.35 kU/L
Potato (White), IgE       LT 0.35 kU/L
Rice, IgE                 LT 0.35 kU/L
Rye, IgE                  LT 0.35 kU/L
Soybean, IgE              LT 0.35 kU/L
Strawberry, IgE           LT 0.35 kU/L
Tomato, IgE               LT 0.35 kU/L
White/Navy Bean, IgE      LT 0.35 kU/L
Wheat, IgE                LT 0.35 kU/L
ALLERGENS, PEDIATRIC PROFILE 11PEDS11PEDS11FEIA
D. farinae (Mite),IgE      LT 0.35 kU/L
Cat Dander, IgE            LT 0.35 kU/L
Dog Dander, IgE            LT 0.35 kU/L
Cows Milk, IgE             LT 0.35 kU/L
Soybean, IgE               LT 0.35 kU/L
Egg White, IgE             LT 0.35 kU/L
Wheat, IgE                 LT 0.35 kU/L
Peanut, IgE                LT 0.35 kU/L
Codfish (Whitefish), IgE   LT 0.35 kU/L
Cockroach, IgE             LT 0.35 kU/L
Alternaria tenuis, IgE     LT 0.35 kU/L
ALLERGENS, ROCKY MOUNTAIN 15RMS15RMS15FEIA
D. farinae (Mite),IgE      LT 0.35 kU/L
Cat Dander, IgE            LT 0.35 kU/L
Dog Dander, IgE            LT 0.35 kU/L
Redtop Bentgrass, IgE      LT 0.35 kU/L
Bermuda Grass, IgE         LT 0.35 kU/L
Cockroach, IgE             LT 0.35 kU/L
Alternaria tenuis, IgE     LT 0.35 kU/L
Grey Alder Tree, IgE       LT 0.35 kU/L
Box Elder, IgE             LT 0.35 kU/L
Cottonwood Tree, IgE       LT 0.35 kU/L
Elm Tree, IgE              LT 0.35 kU/L
Mountain Cedar(Juniper)    LT 0.35 kU/L
 IgE
Oak Tree, IgE              LT 0.35 kU/L
Kochia (Firebush), IgE     LT 0.35 kU/L
Russian Thistle(Saltwort), LT 0.35 kU/L
 IgE
ALLERGENS, SEAFOOD PROFILE 7SEAFD7SEAFD7FEIA
Codfish (whitefish), IgE      LT 0.35 kU/L
Clam, IgE                     LT 0.35 kU/L
Crab, IgE                     LT 0.35 kU/L
Lobster, IgE                  LT 0.35 kU/L
Salmon, IgE                   LT 0.35 kU/L
Shrimp, IgE                   LT 0.35 kU/L
Tuna, IgE                     LT 0.35 kU/L
ALLERGENS, SOUTHERN CALIFORNIA 21SCAL21SCAL21FEIA
D. pteronyssinus (Mite),   LT 0.35 kU/L
 IgE
D. farinae (Mite), IgE     LT 0.35 kU/L
Cat Dander, IgE            LT 0.35 kU/L
Dog Dander, IgE            LT 0.35 kU/L
Bermuda Grass, IgE         LT 0.35 kU/L
Brome Grass, IgE           LT 0.35 kU/L
Cultivated Oat, IgE        LT 0.35 kU/L
Cockroach, IgE             LT 0.35 kU/L
Alternaria tenuis, IgE     LT 0.35 kU/L
Aspergillus fumigatus, IgE LT 0.35 kU/L
Cladosporium herbarum, IgE LT 0.35 kU/L
Box Elder, IgE             LT 0.35 kU/L
Oak Tree, IgE              LT 0.35 kU/L
Olive Tree, IgE            LT 0.35 kU/L
Walnut Tree, IgE           LT 0.35 kU/L
Maple Leaf Sycamore Tree,  LT 0.35 kU/L
 IgE
Japanese Cedar, IgE        LT 0.35 kU/L
False Ragweed, IgE         LT 0.35 kU/L
Russian Thistle(Saltwort), LT 0.35 kU/L
 IgE
Pigweed, IgE               LT 0.35 kU/L
Scale (Lenscale), IgE      LT 0.35 kU/L
ALLERGENS, TREE PROFILE 11TREE11TREE11FEIA
Box Elder Tree, IgE         LT 0.35 kU/L
Grey Alder Tree, , IgE      LT 0.35 kU/L
Common Silver Birch Tree,   LT 0.35 kU/L
 IgE
Cottonwood Tree, IgE        LT 0.35 kU/L
Elm Tree, IgE               LT 0.35 kU/L
Hazelnut Tree, IgE          LT 0.35 kU/L 
Mountain Cedar (Juniper),   LT 0.35 kU/L
 Tree, IgE
Mulberry Tree, IgE          LT 0.35 kU/L
Oak Tree, IgE               LT 0.35 kU/L
Olive Tree, IgE             LT 0.35 kU/L
Walnut Tree,  IgE           LT 0.35 kU/L
ALLERGENS, WEED PROFILE 12WEED12WEED12FEIA
Cocklebur, IgE              LT 0.35 kU/L
English Plantain (Ribwort), LT 0.35 kU/L
 IgE
Kochia (Firebush), IgE      LT 0.35 kU/L
Lamb's Quarters (Goosefoot),LT 0.35 kU/L
 IgE
Rough Marsh Elder, IgE      LT 0.35 kU/L
Mugwort, IgE                LT 0.35 kU/L 
Nettle, IgE                 LT 0.35 kU/L
Short (Common) Ragweed,     LT 0.35 kU/L
 IgE
Russian Thistle (Saltwort), LT 0.35 kU/L
 IgE
Scale (Lenscale), IgE       LT 0.35 kU/L
Sheep Sorrel (Yellow Dock), LT 0.35 kU/L
 IgE
Pigweed,IgE                 LT 0.35 kU/L
ALPHA SUBUNITS PITUITARYALPHA.PGHASUBRIA
Alpha Subunit                     ng/mL
 Preterm infants:         not established,
  likely similar to term infants for
  preterm infants born GT 20/40.
 Term infants (36-40/40), age LT 1
  day:                    50.0 or less.
 1 day-LT 3 mo:           10 or less, 
  majority, 4 or less.
 3 mo-LT 2 yrs:           0.8 or less
 2 yrs to puberty onset:  0.6 or less
  majority undetectable (LT 0.3).
 Tanner II-IV:            1 or less
 Adults:                  1.2 or less,
  some females may exceed this value by
  up to 4-fould just prior to ovulation.
  The high, but rapidly falling, free
  alpha-subunit levels in neonates are
  believed to stem from two sources.
   1. Free alpha-subunit of hCG, produced
   in the placenta along with intact hCG,
   which has passed the placental barrier-
   fetal serum hCG concentrations near
   term are approxiamtely 1/400th of the
   corresponding maternal serum concent-
   rations resulting in fetal hCG levels
   of 10-50 IU/L at birth. Clearance half-
   life of this alpha-subunit fraction is
   2-3 days.
   2. Free alpha-subunit produced in the
   fetal pituitary along with LH, FSH, &
   TSH-pituitary glycoprotein hormone 
   levels exhibit short-lived elevations
   in newborns, believed to be due to
   immaturity of their negative feedback
   regulation by peripheral hormones.
   Puberty onset (transition from Tanner
   stage I to Tanner stage II) occurs for
   boys at median age of 11.5 (+/-2) years
   and for girls at a median age of 10.5
   (+/-2) years. There is evidence that 
   it may occur up to 1 year earlier in
   obese girls and in African-American 
   girls. For boys, there is no proven
   relationship between puberty onset and
   body weight, or ethnic origin.
   Progression through Tanner stages is
   variable. Tanner stage V (adult) should
   be reached by age 18.
   Adult reference values based on Mayo
   studies.
ALPHA-1 ANTITRYPSIN, FECESA1AFA1AFRadial Immunodiffusion
Alpha-1 Antitrypsin  0.00-0.62    mg/g
ALPHA-1-ANTITRYPSINAATAATTurbidimetric
Alpha-1-Antitrypsin  100-200 mg/dL
ALPHA-1-ANTITRYPSIN PHENOTYPEAAT-PHENOAATPHIsoelectric Focusing/ Immunoturbidimetric
AAT-Phenotype
Alpha-1-Antitrypsin  100-200   mg/dL
 Caution: an interpretation is advised
 if the patient has been transfused
 within the previous 14 days.
ALPHA-FETO PROTEIN & HCG SCREENAFP.HCG.SCRAFPHCGImmunometric
Alpha-feto protein and HCG Screen
 Separate Report to Follow
ALPHA-FETO PROTEIN (MATERNAL)AFPAFPMSImmunometric
AFP                               ng/mL
Gestational age                   wk
Maternal Weight                   lbs
MOM
Weight corrected MOM
 30 yrs and under  0.40-2.50 MOM
 Over 30 yrs old   0.50-2.50 MOM
 2.50 MOM equals OSB Risk of 1/605
Diabetic Corrected MOM
Comment
ALPHA-FETO PROTEIN (NON-MATERNAL)AFP-NMAFPTMImmunometric
Alpha-feto protein
 Males & non-pregnant females 0.6-6.6 ng/mL
ALPHA-FETO PROTEIN, AMNIOTIC FLUID (REFLEXIVE)AFAFPAFAFPImmunometric
Blood Present
Alpha-feto Protein,                  ug/mL
 Amniotic Fluid
MoM                  LT 2.0         MoM                
Interpretation       Negative Screen
Fetal Hemoglobin F   Negative
ALPHA-GLOBIN GENE ANALYSISALGGAALGGAPCR. MLPA and Luminex
Specimen
Specimen ID
Source
Order date
Method
Result
Interpretation
Amendment
Reviewed by
Release date
ALPRAZOLAMXANAXALPRAZGC
Alprazolam                           ng/mL
 Anxiety        10-40 (Dose 1-4 mg/d)  
 Phobia & Panic 50-100 (Dose 6-9 mg/d)
 The lowest possible effective dose should
 be used, as side effected increase & anti-
 anxiety efficiency decrease as dosage
 increases.
ALTSGPTALTEnzymatic
ALT  5-50   U/L
ALUMINUM, PLASMAALUMINUMALElectrothermal (Flameless) AAS
Aluminum   ug/L
 0-10 Normal
 0-40 Normal for dialysis patients
 10-60 Increased aluminum uptake
 60-100 Potential clinical problems
 GT 100 Generally leads to clinical symptoms
ALUMINUM, URINEALU-UALUUQICP/MS
Collection Period                hr
Volume                           mL
Creatinine, Urine                mg/dL
Creatinine, Urine                mg/d
 M 0-2 yrs       Not established 
   3-8 yrs       140-700
   9-12 yrs      300-1300
   13-17 yrs     500-2300
   18-50 yrs     1000-2500    
   51-80 yrs     800-2100
   81+ yrs       600-2000
 F 0-2 yrs       Not established
   3-8 yrs       140-700
   9-12 yrs      300-1300
   13-17 yrs     400-1600
   18-50 yrs     700-1600
   51-80 yrs     500-1400
   81+ yrs       400-1300
Aluminum, Urine     0-7           ug/L
Aluminum, Urine     0-10          ug/d
Aluminum, Urine     No reference  ug/gCr
                    range established.
                    Urine aluminum values
                    do not correlate well
                    with exposure. Elevated
                    levels should be 
                    confirmed with a second
                    specimen due to a high
                    susceptibility of the
                    specimen to collection-
                    related environmental
                    contamination.
AMENORRHEA PROFILEAMENAMENICMA
LH                             mIU/mL
 M Prepubertal      0-1.0 
   Pubertal         0.4-7.0
   Adult            1.7-8.6                 
 F
  Prepubertal       0-1.0
  Pubertal          0.4-12.0
  Follicular        2.4-12.6 
  Midcycle peak     14.0-95.6
  Luteal phase      1.0-11.4  
  Post menopausal   7.7-58.5
FSH                            mIU/mL
 M  Prepubertal     0-4.5
    Pubertal        0.3-9.0
    Adult           1.4-11.2    
 F  Prepubertal     0-4.5
    Pubertal        0.3-9.0
    Follicular      3.2-11.3
    Midcycle peak   4.2-19.4       
    Luteal phase    1.5-6.9                   
    Postmenopausal  23.2-121.3
Prolactin                     ng/mL
 M                  1.6-18.8   
 Non-Pregnant
  Females           1.4-24.2
AMIKACIN (SINGLE + CREAT)AMIKAMIKRFPIA
Amikacin                       ug/mL
 Trough     4.0-8.0    Toxic GT 8.0  
 Peak       10.0-30.0  Toxic GT 35.0  
Creatinine                     mg/dL
 M          0.7-1.5            
 F          0.6-1.2
AMIKACIN, PEAKAMIK.PKAMIKPKFPIA
Amikacin,         ug/mL
 Peak  10.0-30.0   
 Toxic GT 35.0
Creatinine        mg/dL           
 F  0.6-1.2       
 M  0.7-1.5
AMIKACIN, TROUGHAMIK.TRAMIKTRFPIA
Amikacin,                 ug/mL
 Trough   4.0-8.0         
 Toxic    GT 8.0
Creatinine                mg/dL
 F        0.6-1.2        
 M        0.7-1.5
AMINO ACIDS, PLASMA (QUANTITATIVE)AA.QUANTAAQHPLC
Taurine                   umol/L
 Newborn      19-265
 1 mo-5 yrs   11-93
 6+ yrs       0-240
Aspartic Acid             umol/L
 Newborn      0-8
 1 mo-5 yrs   3-12
 6+ yrs       0-14
OH-Proline                umol/L
 Newborn      18-72
 1 mo-5 yrs   0-50
 6+ yrs       0-50
Threonine                 umol/L 
 Newborn      65-147
 1 mo-5 yrs   40-225
 6+ yrs       74-202
Serine                    umol/L
 Newborn      62-161
 1 mo-5 yrs   93-176
 6+ yrs       71-181
Asparagine                umol/L
 Newborn      6-33
 1 mo-5 yrs   23-79
 6+ yrs       32-62
Glutamic Acid             umol/L
 Newborn      30-103
 1 mo-5 yrs   11-79
 6+ yrs       7-65
Glutamine                 umol/L
 Newborn      243-822
 1 mo-5 yrs   475-746
 6+ yrs       360-740
Proline                   umol/L
 Newborn      144-329
 1 mo-5 yrs   40-332
 6+ yrs       58-324
Glycine                   umol/L
 Newborn      106-318
 1 mo-5 yrs   105-318
 6+ yrs       158-302
Alanine                   umol/L
 Newborn      132-455
 1 mo-5 yrs   148-475
 6+ yrs       193-545
Citrulline                umol/L
 Newborn      3-36
 1 mo-5 yrs   8-47
 6+ yrs       19-52
Valine                    umol/L                   
 Newborn      78-264
 1 mo-5 yrs   85-334
 6+ yrs       156-288
Cystine                   umol/L
 Newborn      26-71
 1 mo-5 yrs   23-68
 6+ yrs       36-58
Methionine                umol/L
 Newborn      6-36
 1 mo-5 yrs   5-34
 6+ yrs       16-37
Isoleucine                umol/L
 Newborn      27-80
 1 mo-5 yrs   13-81
 6+ yrs       38-95
Leucine                   umol/L
 Newborn      61-183
 1 mo-5 yrs   40-158
 6+ yrs       79-174
Tyrosine                  umol/L
 Newborn      32-124
 1 mo-5 yrs   24-110
 6+ yrs       43-88
Phenylalanine             umol/L
 Newborn      16-71
 1 mo-5 yrs   24-101
 6+ yrs       39-76
Ornithine                 umol/L
 Newborn      38-207
 1 mo-5 yrs   27-117
 6+ yrs       19-81
Lysine                    umol/L
 Newborn      71-272
 1 mo-5 yrs   85-218
 6+ yrs       108-233
Histidine                 umol/L
 Newborn      32-107
 1 mo-5 yrs   22-108
 6+ yrs       64-106
Arginine                  umol/L              
 Newborn      17-119
 1 mo-5 yrs   32-142
 6+ yrs       44-130
Amino Acids Interpretation
AMINO ACIDS, URINE (QUANTITATIVE)AAU.QUANTAAURQAnion Exchange Chromatography
Amino Acids, Urine (Quantitative)
 Separate Report to Follow
AMINOLEVULINIC ACID, URINEALA-UALAUQChromatography/Spectrophotometry
Collection Period          h
Volume                     mL
Creatinine Urine           mg/dL
Creatinine Urine           mg/d 
 M  0-2 yrs      Not established
    3-8 yrs      140-700
    9-12 yrs     300-1300
    13-17 yrs    500-2300   
    18-50 yrs    1000-2500 
    51-80 yrs    800-2100
    81+ yrs      600-2000
 F  0-2 yrs      Not established
    3-8 yrs      140-700
    9-12 yrs     300-1300
    13-17 yrs    400-1600
    18-50 yrs    700-1600
    51-60 yrs    500-1400
    81+ yrs      400-1300
Aminolevulinic Acid, Urine umol/L
 0-35
Aminolevulinic Acid, Urine umol/d
 0-60
AMIODARONEAMIOAMIOHPLC
Amiodarone                 ug/mL
 1.0-3.0                   
 GT 3.0   Potentially Toxic
Desethlyamiodarone         ug/mL
 No Normals Established
AMITRIPTYLINE & METABOLITEAMIAMITRHPLC
Amitriptyline                     ng/mL
 No reference range established
 for parent drug. See Total for reference
 range, which takes into account all
 metabolites.
Nortriptyline                     ng/mL
 Therapeutic 50-150  Toxic  GT 499  
Total Drug                        ng/mL
 Therapeutic 80-220  Toxic  GT 499 
 Studies have determined that Norpace
 will interfere with the measurement of
 the Amitriptyline metabolite, Nortrip-
 tyline. Nortriptyline results & total
 tricyclic results are not valid for
 patients on Norpace.
AMMONIAAMMAMMThin Layer Colorimetric
Ammonia  9-33    umol/L
AMNIOTIC FLUID SCANDODAMNFSSpectrophotometry
Amniotic Fluid Scan
 Appearance
 Color
 RBCS
 Gestational Age        wk
 Abs at 450             Abs 
 Interpretation
AMOXAPINEAMOXAMOXHPLC
Amoxapine                      ng/mL
8-Hydroxyamoxapine             ng/mL
 Optimal therapeutic range 
 (Amoxapine + Active Metabolite)
 200-400 ng/mL
AMPHETAMINES, SERUMAMPQTSAMPQTSGC/MS
Methamphetamine                  ng/mL
 Therapeutic         10-50
 Tolearnt abusers    GT 200
 This test reports methamphetamine as 
 total of the undifferentiated D & L
 enantiomers. The ratio of these
 enantiomers is important in determing
 whether the source of methamphetamine
 is from over-the-counter medications,
 prescribed medication, or controlled
 substances.
Amphetamine                      ng/mL
 Therapeutic         20-100
 Tolerant abusers    Up to 3000
Methylenedioxyamphetamine        ng/mL
 Excitant stimulant levels are not
 available, but by analogy with
 amphetamine are probably LT 400 ng/mL.
Methylenedioxymetamphetamine     ng/mL
 Peak plasma following a single 50 mg
 oral dose:
 110 at 2 hours post-dose
 20 at 4 hours post-dose
Phendimetrazine                  ng/mL
 Following a single 35 mg oral dose:
 Up to 90
Phenmetrazine                    ng/mL
 Following a single 75 mg oral dose:
 Up to 130
Phentermine                      ng/mL
 Following a single oral dose of
 0.375 ng/kg: Up to 90
PPA/Norpseudoephedrine           ng/mL
 Phenylpropanolamine is a drug as well
 as the metabolite of ephedrine. 
 Norseudoephedrine is a metabolite
 of psuedoephedrine. This test does 
 not differentiate phenylpropanolamine
 from norpseudoephedrine. A positive
 finding indicates that either or both
 of the compounds may be present.
Ephedrine/Pseudoephedrine        ng/mL
 Ephedrine: Usual bronchodilator
 range: 35-80
 Pseudoephedrine: Following chronic 
 oral 360 mg/day dose: 500-640
Chlorphentermine                 ng/mL
 Following a single 100 mg appetite-
 suppressant oral dose: Up to 320
 Action Level: Over 1000
Methentermine                    ng/mL
Benzphetamine                    ng/mL
 Benzphetamine is rapidly metabolized
 to methamphetamine and amphetamine.
Methylenedioxyethylamphetamine   ng/mL
AMYLASEAMYAMYEnzymatic
Amylase  16-108  U/L
AMYLASE ISOENZYMESAMY.ISOAMYISOEnzymatic
Amylase Pancreatic             U/L
 18 mo-6 yrs          0-68
 7-17 yrs             9-39
 18 yrs & more        12-52
Amylase Salivary      9-86     U/L
Amylase Total                  U/L
 13-35 mo             19-92
 3-4 yrs              26-106
 5-12 yrs             30-119
 13 yrs & more        30-110
AMYLASE, FLUIDAMY.FLDAMYFLEnzymatic
Amylase, Fluid            U/L
 No normals established
AMYLASE, URINE (2HR)AMYLASE-URINEAMYU2HEnzymatic
Collection Period     h
Volume                mL
Amylase, Urine  0-28  U/2h
AMYLASE, URINE (PANCREATIC TRANSPLANT)AMY.PANCRAMYU12Enzymatic
Collection Period      h
Volume                 mL
Amylase, Urine 0-500   U/L
Amylase, Urine 0-14    U/h
AMYLASE, URINE (QUANTITATIVE)AMYUQAMYUQEnzymatic
Collection Period      h
Volume                 mL
Amylase, Urine   0-14  U/h
AMYLASE, URINE (RANDOM)AMY.RAMYUREnzymatic
Amylase, Urine (Random)  0-500  U/L
AMYLASE/CREATININE CLEARANCEAMY-CLAMYCLEnzymatic, Colorimetric, Calculation
Creatinine
 F                 0.6-1.2   mg/dL
 M                 0.7-1.5   mg/dL
Creatinine, Urine
 No normals established      mg/dL
Amylase            16-108    U/L
Amylase, Urine     0-500     U/L       
Amylase/Creatinine 0.2-3.2
Amylase/Creatinine           Ratio
 Clearance Ratio   LT 5
AMYLASE/CREATININE, URINE (RANDOM)AMY-UAMYCUREnzymatic
Amylase, Urine        0-500    U/L
Creatinine, Urine
 No normals established        mg/dL
Amylase/Creatinine    0.2-3.2  Ratio
ANA SCREEN (REFLEXIVE)ANAMPANAMPMultiplex luminex
ANA                        Negative
 A multiplex screen for 11 autoantibodies
 (dsDNA, Sm, Ribosomal P, Chromatin, RNP, 
 SmRNP, Scl-70, Centromere B, SSA, SSB and
 J0-1) was performed and no autoantibodies
 were detected. A negative multiplex ANA
 does not rule out all possibility of a 
 connective tissue or autoimmune disease,
 and further studies should be considered
 if clinical suspicion is high.
DSDNA Autoantibody    Negative       LT 5         IU/mL
                      Indeterminate  5-9
                      Positive       10 or more
SM Autoantibody       Negative       LT 1.0       AI
                      Positive       1.0 or more  
Ribosomal P Auto-     Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
Chromatin Auto-       Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
RNP Autoantibody      Negative       LT 1.0       AI
                      Positive       1.0 or more 
SMRNP Auto-           Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
SCL-70 Auto-          Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
Centromere B Auto-    Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
SSA (RO) Auto-        Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
SSB (LA) Auto-        Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
JO-1 Autoantibody     Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
ANALYZERANALZ4ANALZ4EIA/LIA
ANA                        LT 7.5    IU/mL
ANA Pattern       
dsDNA AutoAbs              LT 5.0    
RNP/Sm    Negative         LT 5.0
          Borderline       5.0-10.0
          Positive         GT 10.0
Sm(Smith) Negative         LT 5.0    
 IgG      Borderline       5.0-10.0        
 AutoAbs  Positive         GT 10.0
SS-A IgG  Negative         LT 5.0    
 AutoAbs  Borderline       5.0-10.0
          Positive         GT 10.0
SS-B IgG  Negative         LT 5.0    
 AutoAbs  Borderline       5.0-10.0
          Positive         GT 10.0
Scl-70    Negative         LT 5.0    
 IgG      Borderline       5.0-10.0
 AutoAbs  Positve          GT 10.0
Thyroid                    LT 60     U/mL
 Peroxidase
 AutoAbs
C3 Complement              82-235    mg/dL
C4 Complement              16-70     mg/dL
Rheumatoid Factor          LT 60     IU/mL
Ribosmal  Negative         LT 5.0    Units
 P        Borderline       5.0-10.0
 AutoAbs  Positive         GT 10.0
ANCA PANEL (REFLEXIVE)ANCAMEANCAMEMultiplex luminex, IFA, ELISA
ANA                        Negative
 A multiplex screen for 11 autoantibodies
 (dsDNA, Sm, Ribosomal P, Chromatin, RNP, 
 SmRNP, Scl-70, Centromere B, SSA, SSB and
 J0-1) was performed and no autoantibodies
 were detected. A negative multiplex ANA
 does not rule out all possibility of a 
 connective tissue or autoimmune disease,
 and further studies should be considered
 if clinical suspicion is high.
DSDNA Autoantibody    Negative       LT 5         IU/mL
                      Indeterminate  5-9
                      Positive       10 or more
SM Autoantibody       Negative       LT 1.0       AI
                      Positive       1.0 or more  
Ribosomal P Auto-     Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
Chromatin Auto-       Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
RNP Autoantibody      Negative       LT 1.0       AI
                      Positive       1.0 or more 
SMRNP Auto-           Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
SCL-70 Auto-          Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
Centromere B Auto-    Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
SSA (RO) Auto-        Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
SSB (LA) Auto-        Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
JO-1 Autoantibody     Negative       LT 1.0       AI
 antibody             Positive       1.0 or more
ANCA Titer, IFA
ANCA Pattern
Proteinase 3                         LT 3.5       U/mL
 Antibody
Myeloperoxidase                      LT 9.0       U/mL
 Antibody
ANDROSTENEDIONEANDROS.SANDROSICMA
Androstenedione                  ng/mL
 F  7-9 yrs            0.0-0.9
    10-11 yrs          0.0-3.0
    12-13 yrs          0.4-3.4
    14-15 yrs          0.7-4.3
    16-17 yrs          0.9-4.1
    18-40 yrs          0.5-4.3
    41 yrs +           0.4-2.7
    Postmenopausal     LT 1.0
    Tanner Stage I     LT 1.6    ng/mL
    Tanner Stage II    LT 2.2
    Tanner Stage III   0.6-4.4
    Tanner Stage IV-V  0.9-3.8
 M  7-9 yrs            0.0-0.8   ng/mL
    10-11 yrs          0.0-1.3
    12-13 yrs          0.0-1.6
    14-15 yrs          0.4-2.9
    16-17 yrs          1.1-3.1
    18-40 yrs          0.9-2.9
    41 yrs +           0.8-2.2
    Tanner Stage I     LT 0.9    ng/mL
    Tanner Stage II    LT 1.4
    Tanner Stage III   LT 2.6
    Tanner Stage IV-V  1.0-3.0
ANDROSTERONE, URINEANDR-UANDRUQGC/MS
Collection Period                 Hrs
Volume                            mL
Androsterone (Urine)              ug/24h
 M  12 yrs or less    6.0-725
    More than 12 yrs  234-2,703           
 F  12 yrs or less    6.0-725
    More than 12 yrs  55-1,589
ANEMIA PROFILEANEMPRANEMPRAutomated/Hemagglutination/Colorimetric
Anemia Profile
 Autoheme
 Retic Count                 %
  0-2 days        3.0-7.0
  3-6 days        1.0-3.0
  7 days-1 mo     0.0-1.0
  2 mo-4 yr       1.0-2.0
  5+ yrs          0.4-2.7    
 Retic Abs                   K/uL
  5+ yrs          16-123
 Immature Retic Fraction     %
  1+ yrs          0.17-0.43
 Direct Coombs    Negative
 Iron            
  M 35-190                   ug/dL
  F 30-150
 Iron Binding Capacity
  M 230-430                  ug/dL
  F 250-450
 % Saturation
  M 20-55                    %
  F 15-50
 Interpretation
 Reviewed by
ANGIOTENSIN CONVERTING ENZYMEANGIOACESpectrophotometric
Angiotensin Converting Enzyme  4-60 U/L
ANGIOTENSIN CONVERTING ENZYME, CSFACECFACECFSpectrophotometry
Angiotensin Converting Enzyme, CSF   U/L
 0.0-2.5
ANNA TITER & WB CONFIRMATIONANEUCOANEUCOIFA & Western blot
ANNA Titer                  LT 1:40
ANNA Western Blot           Negative
ANNA, TITER & WB CONFIRMATION, SFASFCONASFCONIFA and Western Blot
ANNA Titer, SF       LT 1:1
ANNA Wester Blot     Negative
ANTABUSEANTABUSEABUSEGC
Antabuse              ug/mL
 None detected
 Therapeutic  0.3-1.5
ANTI NEURONAL NUCLEAR ANTIBODY, SF (REFLEXIVE)ANEUSFANEUSFIFA
Anti Neuronal Nuclear Ab, SF      Negative
ANTI-CONVULSANT PROFILECONV-PANCONVICMA
Dilantin                                ug/mL
 Therapeutic  10.0-20.0  Toxic  GT 25.0 
Phenobarbital                           ug/mL 
 Therapeutic  15.0-40.0  Toxic  GT 50.0
ANTI-DNA (FARR TECHNIQUE)DNA.FARRDNAFARIA
Anti-DNA (Farr Technique)  LT 5.0 IU/mL
ANTI-GLIADIN ANTIBODIES, IGA & IGGGLIGAGLIGAELISA
Anti-Gliadin Ab, IgA         U/mL
 Negative    LT 5.0
 Positive    5.0 or greater
Anti-Gliadin Ab, IgG         U/mL
 Negative    LT 10.0
 Positive    10.0 or greater
ANTI-ISLET CELL ANTIBODYISLETISLETIFA
Anti-Islet Cell Ab             Titer
 LT 1:4  No antibody detected
 Islet cell antibodies have been associated
 with "autoimmune" endocrine disorders and
 insulin-dependent diabetes. This disorder
 is characterized by the presence of
 antibodies in patients that may be
 detected years before the onset of the
 clinical symptoms. To calculate Juvenile
 Diabetes Foundation (JDF) units; multiply
 the titer x 5 (1.8  8x5=40 JDF Units).
ANTI-MYOCARDIAL ANTIBODY (REFLEXIVE)ABMYOABMYOIndirect Fluorescent Ab
Myocardial Ab, IgG Screen   LT 1:20              
Myocardial Ab, IgG Titer    LT 1:20
ANTI-NEURONAL CELL ANTIBODIESNCABNCABAEIA
Anti-Neuronal Cell Ab   0-54 Units
ANTI-NEUTROPHIL ANTIBODYANETABANETABFlow Cytometry
Anti-neutrophil Ab     Negative                             
 Anti-neutrophil antibody has been
 implicated in causing the
 neutropenia of various autoimmune
 disorders including Felty's
 Syndrome, SLE and drug-induced
 neutropenia. Isoimmune destruction
 may be caused by antibodies to
 neutrophil-specific antigens and
 HLA antigens in febrile
 transfusion reactions and iso-
 immune neonatal neutropenia.
 Circulating antibodies in patient's
 serum are measured by flow
 cytometry after incubation with normal
 neutrophils. Values greater
 than 2 standard deviations of the
 control population are interpreted
 as "weakly positive" and greater
 than 3 standard deviations,
 "positive".
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY SCREEN (REFLEXIVE)ANCASRANCASRIFA
ANCA Titer, IFA     LT 1:20 Negative
ANCA Pattern
ANTI-PARIETAL CELL ANTIBODY, TOTAL, IGA, IGG & IGMPARIETAL CELL ABAPCAIFA
Parietal Cell Ab, Total(IgA, IgG, IgM)
 Negative LT 1:20
ANTI-SMOOTH MUSCLE ANTIBODYASMASMIFA
Smooth Muscle Ab  Negative  LT 1:40
ANTI-THYROID ANTIBODIESTABTABICMA
Thyroglobulin Autoantibodies      IU/mL
 0.0-40.0                  
Thyroid Peroxidase Autoantibodies IU/mL
 0.0-35.0
ANTIBODY IDENTIFICATIONAB IDMABIDSolid Phase/Hemagglutination
Antibody Screen 
Antibody ID
Antibody Titer
ANTICARDIOLIPIN ANTIBODY PANELCARD.ABCARDELISA
Cardiolipin Ab, IgG           GPL U/mL
 Negative          LT 10 
 Indeterminate     10-19
 Low-Med Positive  20-80
 Strong Positive   GT 80                   
Cardiolipin Ab, IgM           MPL U/mL
 Negative          LT 10
 Indeterminate     10-19
 Low-Med Positive  20-80
 Strong Positive   GT 80
ANTICARDIOLIPIN ANTIBODY, IGACARDACARDAELISA
Cardiolipin Antibody, IgA     Negative   LT 13          APL U/mL
                              Positive   13 or more
ANTICARDIOLIPIN ANTIBODY, IGGCARDGCARDGELISA
Cardiolipin Antibody, IgG     Negative         LT 10          GPL U/mL
                              Indeterminate    10-19
                              Low-Med Positive 20-80
                              Strong Positive  GT 80
ANTICARDIOLIPIN ANTIBODY, IGMCARDMCARDMELISA
Cardiolipin Antibody, IgM     Negative         LT 10          MPL U/mL
                              Indeterminate    10-19
                              Low-Med Positive 20-80
                              Strong Positive  GT 80
ANTINEURONAL NUCLEAR ANTIBODY (REFLEXIVE)ANEUANEUIFA
Anti-Neuronal Nuclear Ab       Negative
ANTINUCLEAR ANTIBODY TITER BY IFAIFANAIFANAIFA
ANA by IFA Titer    LT 1:40      Titer
ANA by IFA Pattern
ANTIPHOSPHATIDYLSERINE, IGAAPSAAPSAELISA
Antiphosphatidylserine,   Negative      LT 20       APS U/mL
 IgA                      Positive      20 or more
 The presence of phosphatidylserine Abs maybe
 associated with anti-phospholipid
 syndrome characterized by recurrent
 fetal loss, thrombosis and
 thrombocytopenia.
ANTIPHOSPHATIDYLSERINE, IGGAPSGAPSGELISA
Antiphosphatidylserine,   Negative      LT 11       GPS U/mL
 IgG                      Positive      11 or more
 The presence of phosphatidylserine Abs maybe
 associated with anti-phospholipid
 syndrome characterized by recurrent
 fetal loss, thrombosis and
 thrombocytopenia.
ANTIPHOSPHATIDYLSERINE, IGMAPSMAPSMELISA
Antiphosphatidylserine,   Negative      LT 25       MPS U/mL
 IgM                      Positive      25 or more
 The presence of phosphatidylserine Abs maybe
 associated with anti-phospholipid
 syndrome characterized by recurrent
 fetal loss, thrombosis and
 thrombocytopenia.
ANTIPHOSPHOLIPID PANEL 1, (REFLEXIVE)APP1AP1ELISA and Electromechanical
Cardiolipin Ab IgG    Negative          LT 10       GPL U/mL
                      Indeterminate     10-19 
                      Low-Med Positive  20-80
                      Strong Positive   GT 80
Cardiolipin Ab IgM    Negative          LT 10       MPL U/mL
                      Indeterminate     10-19
                      Low-Med Positive  20-80
                      Strong Positive   GT 80
Beta-2 Glycoprotein   Negative          LT 20       U/mL
 1 Ab, IgG            Positive          20 or more
Beta-2 Glycoprotein   Negative          LT 10       U/mL
 1 Ab, IgM            Positive          10 or more
PT, Patient           0-1 month         13.0-20.0   sec
                      2+ months         11.9-15.0
PT, PT/NT Mix                                       sec
Thrombin Time, Patient                  15.6-20.0   sec
TT, PT/PS Mix                                       sec
APTT, Patient         0-1 month         40-50       sec
                      2 mon-4 yrs       25-40
                      5+ years          26-36
APTT Control
APTT, PT/CT Mix
PNP                                     0.0-7.0
dRVVT                                   31.8-45.7   sec
dRVVT Mix Ratio                         LT 1.2
dRVVT Confirm Ratio                     LT 1.2
dRVVT Confirm Mix Ratio                 LT 1.2
ANTIPHOSPHOLIPID PANEL 2, (REFLEXIVE)APP2APP2ELISA and Electromechanical
Antiphosphatidylserine,   Negative      LT 20       APS U/mL
 IgA                      Positive      20 or more
 The presence of phosphatidylserine Abs maybe
 associated with anti-phospholipid
 syndrome characterized by recurrent
 fetal loss, thrombosis and
 thrombocytopenia.
Antiphosphatidylserine,   Negative      LT 11       GPS U/mL
 IgG                      Positive      11 or more
 The presence of phosphatidylserine Abs maybe
 associated with anti-phospholipid
 syndrome characterized by recurrent
 fetal loss, thrombosis and
 thrombocytopenia.
Antiphosphatidylserine,   Negative      LT 25       MPS U/mL
 IgM                      Positive      25 or more
 The presence of phosphatidylserine Abs maybe
 associated with anti-phospholipid
 syndrome characterized by recurrent
 fetal loss, thrombosis and
 thrombocytopenia.
Cardiolipin Ab IgA    Negative          LT 13       APL U/mL
                      Positive          13 or more     
Cardiolipin Ab IgG    Negative          LT 10       GPL U/mL
                      Indeterminate     10-19 
                      Low-Med Positive  20-80
                      Strong Positive   GT 80
Cardiolipin Ab IgM    Negative          LT 10       MPL U/mL
                      Indeterminate     10-19
                      Low-Med Positive  20-80
                      Strong Positive   GT 80
dRVVT                                   31.8-45.7   sec
dRVVT Mix Ratio                         LT 1.2
 Negative for Lupus Inhibitor screen.
dRVVT Confirm Ratio                     LT 1.2
 Negative for Lupus Inhibitor screen.
dRVVT Confirm Mix Ratio                 LT 1.2
 Negative for Lupus Inhibitor screen.
ANTIPHOSPHOLIPID PANEL 3, (REFLEXIVE)APP3APP3ELISA and Electromechanical
Antiphosphatidylserine,   Negative      LT 20       APS U/mL
 IgA                      Positive      20 or more
 The presence of phosphatidylserine Abs maybe
 associated with anti-phospholipid
 syndrome characterized by recurrent
 fetal loss, thrombosis and
 thrombocytopenia.
Antiphosphatidylserine,   Negative      LT 11       GPS U/mL
 IgG                      Positive      11 or more
 The presence of phosphatidylserine Abs maybe
 associated with anti-phospholipid
 syndrome characterized by recurrent
 fetal loss, thrombosis and
 thrombocytopenia.
Antiphosphatidylserine,   Negative      LT 25       MPS U/mL
 IgM                      Positive      25 or more
 The presence of phosphatidylserine Abs maybe
 associated with anti-phospholipid
 syndrome characterized by recurrent
 fetal loss, thrombosis and
 thrombocytopenia.
Cardiolipin Ab IgA    Negative          LT 13       APL U/mL
                      Positive          13 or more     
Cardiolipin Ab IgG    Negative          LT 10       GPL U/mL
                      Indeterminate     10-19 
                      Low-Med Positive  20-80
                      Strong Positive   GT 80
Cardiolipin Ab IgM    Negative          LT 10       MPL U/mL
                      Indeterminate     10-19
                      Low-Med Positive  20-80
                      Strong Positive   GT 80
Beta-2 Glycoprotein   Negative          LT 10       U/mL
 1 Ab, IgA            Positive          10 or more
Beta-2 Glycoprotein   Negative          LT 20       U/mL
 1 Ab, IgG            Positive          20 or more
Beta-2 Glycoprotein   Negative          LT 10       U/mL
 1 Ab, IgM            Positive          10 or more
dRVVT                                   31.8-45.7   sec
dRVVT Mix Ratio                         LT 1.2
 Negative for Lupus Inhibitor screen.
dRVVT Confirm Ratio                     LT 1.2
 Negative for Lupus Inhibitor screen.
dRVVT Confirm Mix Ratio                 LT 1.2
 Negative for Lupus Inhibitor screen.
ANTIPHOSPHOLIPID SYNDROME EVALUATION (REFLEXIVE)APSEEXAPSEEXEIA, Clot detection
Antiphospholipid Syndrome Evaluation
 See separate report
ANTITHROMBIN III ACTIVITYTHROMBIN III.ACTAT3Chromogenic
Antithrombin III Activity  85-126  %
ANTITHROMBIN III ANTIGENTHROMBIN.III.AGAT3AGImmuno-turbidimetric
Antithrombin III Antigen  21-33  mg/dL
APO E MUTATION DETECTION FOR CARDIOVASCULAR RISKAPOEAPOE